Functionalizing Silica Coated Iron Oxide Nanoparticles for Imaging and Targeted Treatment of Pancreatic Cancer by Nagalla, Raji
Wellesley College
Wellesley College Digital Scholarship and Archive
Honors Thesis Collection
2014
Functionalizing Silica Coated Iron Oxide




Follow this and additional works at: https://repository.wellesley.edu/thesiscollection
This Dissertation/Thesis is brought to you for free and open access by Wellesley College Digital Scholarship and Archive. It has been accepted for
inclusion in Honors Thesis Collection by an authorized administrator of Wellesley College Digital Scholarship and Archive. For more information,
please contact ir@wellesley.edu.
Recommended Citation
Nagalla, Raji, "Functionalizing Silica Coated Iron Oxide Nanoparticles for Imaging and Targeted Treatment of Pancreatic Cancer"
(2014). Honors Thesis Collection. 203.
https://repository.wellesley.edu/thesiscollection/203
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Functionalizing	  Silica	  Coated	  Iron	  Oxide	  Nanoparticles	  for	  Imaging	  and	  Targeted	  Treatment	  of	  Pancreatic	  Cancer	  	  Raji	  Rao	  Nagalla	  Advisor:	  Nancy	  H.	  Kolodny,	  Chemistry	  Department	  	  	  	  	  	  	  	  	  	  	  	   Submitted	  in	  Partial	  Fulfillment	  of	  the	  	  Prerequisite	  for	  Honors	  in	  Biological	  Chemistry	  	  May	  2014	  ©2014	  Raji	  Rao	  Nagalla	   	  
Nagalla	  2014	  
2	  
Abstract	  The	   treatment	   of	   pancreatic	   cancer	   remains	   a	   challenge	   in	   the	   biomedical	  community.	  Over	  half	   of	   cases	   are	  diagnosed	   after	   the	   cancer	  has	   spread	   to	   other	  tissues,	  and	  in	  these	  cases	  the	  5-­‐year	  survival	  rate	  is	  2%.	  The	  non-­‐specific	  nature	  of	  currently	   available	   chemotherapies	   has	   spurred	   interest	   in	   developing	   vehicles	   to	  deliver	  potent	  therapies	  specifically	  to	  tumors.	  Nanoparticles	  (NPs)	  present	  an	  ideal	  vehicle	   due	   to	   their	   high	   surface	   area,	   small	   size,	   and	   low	   toxicity.	   This	   project	  explored	  the	  functionalization	  of	  silica-­‐coated	  superparamagnetic	  iron	  oxide	  (SPIO)	  NPs	   with	   polyethylene	   glycol	   (PEG)	   and	   antibody	   moieties	   targeting	   pancreatic	  cancer	   tissue.	   Attachment	   of	   multiple	   moieties	   was	   explored	   using	   orthogonal	  surface	   chemistries,	   including	   protein	   thiolation	   with	   2-­‐iminothiolane.	  Quantification	  and	  detection	  of	  conjugated	  moieties	  was	  investigated	  using	  infrared	  spectroscopy.	  In	  vitro	  techniques	  were	  also	  developed	  to	  quantify	  SPIO	  NP	  detection,	  targeting,	  and	  cellular	  internalization,	  using	  magnetic	  resonance	  imaging	  (MRI)	  and	  confocal	   microscopy.	   The	   results	   of	   this	   study	   show	   promise	   for	   the	   selective	  treatment	  of	  pancreatic	  cancer	  using	  silica-­‐coated	  SPIO	  NPs.	  Techniques	  developed	  in	  this	  work	  pave	  the	  way	  for	  understanding	  how	  these	  NPs	  interact	  with	  the	  body	  at	  the	  cellular	  level.	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1.0	  Introduction	  The	   treatment	   of	   pancreatic	   cancer	   remains	   a	   challenge	   in	   the	   biomedical	  community.	  While	  one	  of	  the	  rarest	  forms	  of	  cancer,	  this	  disease	  is	  the	  fourth	  most	  deadly.	  Over	  half	  of	  cases	  are	  diagnosed	  after	  the	  cancer	  has	  spread	  to	  other	  tissues,	  and	   in	   these	   cases	   the	   5-­‐year	   survival	   rate	   is	   2%.1	   The	   remote	   location	   of	   the	  pancreas,	  behind	  the	  stomach	  in	  the	  abdomen,	  leads	  to	  many	  challenges	  in	  diagnosis	  and	  treatment.	  Current	  therapies	  for	  pancreatic	  cancer	  include	  the	  Whipple	  surgical	  procedure,	  radiation,	  and	  chemotherapy.2	  These	  options	  are	  invasive	  and/or	  cause	  extensive	  damage	  to	  healthy	  tissues,	  and	  quality	  of	  life	  is	  often	  severely	  diminished	  for	  survivors.1	  Thus,	  there	  is	  a	  need	  for	  other	  therapeutic	  options.	  This	  thesis	  project	  works	   towards	   creating	   such	  a	   treatment,	  using	  nanoparticles	   (NPs)	   to	   selectively	  treat	  pancreatic	  cancer	  while	  preserving	  healthy	  tissues.	  Nanoparticles	   (NPs),	   each	  about	  1/1000	   the	  width	  of	   a	  human	  hair,	   are	   an	  emerging	  tool	  for	  targeted	  delivery	  of	  therapeutics.	  A	  teaspoon	  of	  these	  particles,	  at	  the	  typical	  concentration	  of	  1016	  particles	  per	  milliliter,	  contains	  the	  surface	  area	  of	  Wellesley’s	   academic	   quad,	   providing	   “real	   estate”	   to	   attach	   large	   quantities	   of	  therapeutics	  and	  targeting	  components	  to	  direct	  the	  therapy	  to	  the	  cancer.	  	  This	   work	   uses	   the	   platform	   of	   silica-­‐coated	   iron	   oxide	   NPs	   to	   build	   a	  multifunctional	   therapy	   traceable	   via	   magnetic	   resonance	   imaging	   (MRI).	   In	  addition	   to	   serving	   as	   a	   vehicle	   for	   therapeutic	   moieties,	   the	   iron	   oxide	   NP	   core	  allows	   for	   tracing	   of	   NPs	   for	   tumor	   localization	   and	   monitoring.	   Visualization	   is	  based	   on	   magnetic	   resonance	   imaging	   (MRI)	   of	   superparamagnetic	   iron	   oxide	  nanoparticles	  (SPIO	  NPs).	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1.1	  Principles	  of	  Magnetic	  Resonance	  Imaging	  Magnetic	   resonance	   imaging	   (MRI)	   uses	   the	   nuclear	   magnetic	   resonance	  (NMR)	   of	  water	   protons	   to	   non-­‐invasively	   gather	   information	   about	   the	   chemical	  environment	   and	   spatial	   organization	   of	   a	   material	   of	   interest.	   The	   low-­‐energy	  electromagnetic	   radiation	   required	   for	   MRI	   makes	   it	   ideal	   for	   imaging	   biological	  systems.	   This	   section	   describes	   the	   theory	   of	   NMR	   and	   MRI,	   followed	   by	   its	  application	   to	   samples	   containing	   superparamagnetic	   iron	   oxide	   (SPIO)	  nanoparticles	  (NPs).	  
1.1.1	  Nuclear	  Magnetic	  Resonance	  NMR	  is	  based	  on	  the	  difference	  in	  energy	  between	  quantum	  mechanical	  spin	  states	  that	  occurs	  in	  nuclei	  with	  non-­‐zero	  spin	  quantum	  numbers	  in	  the	  presence	  of	  an	   external	   magnetic	   field;	   this	   phenomenon	   is	   known	   as	   the	   Zeeman	   Effect.3	  Elements	  whose	  atoms	  have	  an	  odd	  number	  of	  protons,	  neutrons,	  or	  both,	  exhibit	  these	   properties.	   These	   nuclei	   are	   known	   as	   “NMR	   active”	   and	   possess	   magnetic	  dipole	  moments	  (MDMs),	  which	  align	  with	  or	  against	  an	  external	  magnetic	  field.	  The	  isotopes	  13C,	  31P,	  14N,	  and	  19F	  are	  used	  for	  various	  biological	  applications	  of	  NMR	  and	  MRI.	  However,	   1H,	  composing	  63	  percent	  of	  biological	  matter	  due	  primarily	   to	   the	  abundance	  of	  water,	  is	  the	  most	  ubiquitous	  nucleus	  in	  nature	  with	  a	  non-­‐zero	  spin	  quantum	  number	  and	  the	  key	  to	  MRI	  analysis	  of	  biological	  samples.4	  Protons	   have	   two	   spin	   states,	   derived	   from	   their	   spin	   angular	   momentum	  quantum	  number	  (I)	  of	  ½,	  as	  per	  Equation	  1.	  The	  two	  spin	  states	  are	  degenerate	  in	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energy	  in	  the	  absence	  of	  an	  external	  magnetic	  field,	  causing	  each	  state	  to	  be	  equally	  populated	  and	  indistinguishable.	  	  
#	  Spin	  States	  =	  2(I)	  +1	   	   (Equation	  1)	  	  Protons	  in	  a	  sample	  exposed	  to	  an	  external	  magnetic	  field	  will	  have	  a	  slight	  excess	  of	   atoms	   in	   the	  energetically	   favored	   spin	   state	   aligned	  with	   this	   field.	  The	  energy	  spacing	  between	  the	  two	  spin	  states	  depends	  on	  the	  gyromagnetic	  ratio	  (γ)1	  unique	   to	   the	   nucleus	   of	   each	   element	   and	   the	   strength	   of	   the	   external	  magnetic	  field	  (B0)	  (Eqn.	  2).4	  Because	  this	  energy	  is	  very	  small	  compared	  to	  available	  thermal	  energy	   at	   room	   temperature,	   a	   large	   population	   of	   protons	   and/or	   a	   very	   strong	  magnet	  is	  required	  to	  create	  a	  detectable	  population	  difference.5	  
∆E   =   hυ   =   γ !!" !!	   (Equation	  2)	  Looking	  now	  at	  NMR	  through	  the	  lens	  of	  the	  classical	  model,	  we	  can	  consider	  vectors	  representing	  the	  proton	  MDMs	  defined	  above,	  which	  orient	  randomly	  in	  the	  absence	  of	  a	  magnetic	   field	  resulting	   in	  no	  net	  MDM	  (Figure	  1).	  When	  an	  external	  magnetic	  field	  is	  introduced	  along	  the	  z-­‐axis,	  all	  proton	  MDMs	  in	  a	  sample	  will	  align	  axially	  such	  that	  the	  net	  MDM	  is	  oriented	  in	  the	  same	  direction	  as	  the	  magnetic	  field.	  	  




Figure	  1.	  Magnetic	  dipole	  moments	  of	  NMR	  active	  atoms	  in	  the	  A)	  absence	  and	  
B)	   presence	   of	   an	   external	  magnetic	   field.	  The	  magnetic	   field	   is	  directed	  to	  the	  right	  of	  the	  page	  in	  B.2	  In	   addition	   to	   their	   axial	   orientation,	   proton	  MDMs	   also	   classically	   precess	  about	  the	  axis	  of	  the	  external	  magnetic	  field	  at	  the	  Larmor	  frequency	  (ω)	  (Eqn.	  3).	  Also	   known	   as	   the	   resonance	   frequency,	   this	   intrinsic	   parameter	   occurs	   in	   the	  radiofrequency	   range	   and	   corresponds	   to	   the	   difference	   in	   energy	   between	  hydrogen’s	  quantum	  mechanical	  spin	  states.	  
! = !!!	   	   (Equation	  3)	  Resonant	  radiofrequency	  (RF)	  radiation	  is	  used	  to	  manipulate	  the	  precession	  of	  proton	  MDMs.	  An	  RF	  pulse	  applied	  perpendicular	  to	  the	  net	  proton	  MDM	  aligned	  with	  an	  external	  magnetic	  field	  along	  the	  z-­‐axis	  generates	  a	  magnetic	  field	  in	  the	  xy	  plane.	   This	   smaller	   field	   causes	   the	   net	   MDM	   to	   “flip”	   away	   from	   the	   z-­‐axis	   and	  towards	  precession	  in	  the	  transverse	  plane	  (Figure	  2).	  The	  strength	  and	  duration	  of	  the	  RF	  pulse	  determines	  the	  degree	  of	  proton	  MDM	  excitation.6	  Receiver	  coils	  detect	  the	  raw	  signal	  of	  current	  induced	  by	  changes	  in	  the	  transverse	  magnetic	  field.3	  The	  observed	  decay	  of	  transverse	  magnetization	  when	  the	  RF	  pulse	  is	  removed	  provides	  




information	   about	   the	   chemical	   and	   physical	   environment	   surrounding	   these	  protons	  and	  thereby	  about	  the	  samples	  in	  which	  these	  atoms	  exist.	  	  
	  
Figure	  2.	  Use	  of	  radiofrequency	  (RF)	  pulse	  to	  manipulate	  net	  proton	  MDM.	  An	  RF	   pulse	   applied	   perpendicular	   to	   the	   external	   magnetic	   field	   (B0)	   generates	   a	  magnetic	  field	  B1.	  The	  net	  proton	  MDM	  (M0)	  is	  forced	  from	  precession	  around	  B0	  to	  around	  B1,	  in	  a	  path	  following	  the	  gray	  arrow	  in	  a	  rotating	  frame	  of	  reference.5	  	   Neighboring	   sources	   of	   moving	   charge,	   such	   as	   electrons,	   generate	   local	  magnetic	  fields,	  affecting	  the	  relaxation	  of	  proton	  MDMs.	  Figure	  3	  shows	  the	  decay	  of	  transverse	  magnetization	  (MT)	  and	  the	  recovery	  of	  axial	  magnetization	  (MZ)	  that	  occurs	  during	  relaxation.	  The	  receiver	  coil	  records	  the	  free	  induction	  decay	  (FID)	  of	  current,	   proportional	   to	   the	   loss	   of	  MT.	  MRI	   uses	   spatial	   encoding	   to	   generate	   an	  image	  from	  this	  signal.	  






Figure	   3.	   Transverse	   and	   axial	   relaxation	   following	   an	   excitatory	   RF	   pulse.	  Note	  loss	  of	  transverse	  magnetization	  (MT)	  and	  gain	  of	  axial	  magnetization	  (MZ)	  as	  the	   proton	   MDMs	   realign	   with	   and	   against	   the	   external	   magnetic	   field.	   The	  corresponding	   free	   induction	   decay	   (FID)	   recorded	   by	   the	   receiver	   coil	   is	   shown	  over	  time.	  	   1.1.2	  Relaxation	  Parameters	  of	  Nuclear	  Magnetic	  Resonance	  T1,	  T2,	  and	  T2*	  relaxation	  time	  constants	  are	  intrinsic	  values	  that	  characterize	  the	  relaxation	  of	  the	  nuclear	  MDMs	  in	  a	  particular	  material.5	  T1	  is	  the	  time	  required	  for	  a	  63	  percent	  recovery	  of	  the	  net	  MDM	  in	  the	  axial	  direction	  and	  is	  due	  to	  spin-­‐lattice	   relaxation,	   the	   transfer	   of	   energy	   to	   neighboring	   particles	   tumbling	   at	   the	  Larmor	  frequency	  (Eqn.	  4).	  T2	  is	  the	  time	  required	  for	  the	  loss	  of	  63	  percent	  of	  the	  net	   transverse	  MDM	  and	   is	  due	   to	  spin-­‐spin	  relaxation,	   the	  dephasing	  of	  MDMs	   in	  the	  xy	  plane	  (Eqn.	  5).	  T2*	  also	  characterizes	  transverse	  relaxation	  due	  to	  spin-­‐spin	  relaxation	   but	   additionally	   includes	   the	   contribution	   of	   magnetic	   field	  inhomogeneity	   that	   is	   present	   in	   all	   samples,	   no	   matter	   how	   well	   shimmed	   the	  external	  magnetic	  field	  of	  the	  MR	  instrument.4	  











T1	  signal	  intensity	  =	  SIT1	  =	  SIT1	  (0)	  (1	  –	  e-­‐TE/T1)	   (Equation	  4)	  	  T2	  signal	  intensity	  =	  SIT2	  =	  SIT2(0)	  (e-­‐TE/T2)	   	   (Equation	  5)	  SPIO	  NPs,	  as	  their	  name	  implies,	  are	  superparamagnetic,	  and	  thus	  act	  as	  tiny	  bar	  magnets	   in	   an	   external	  magnetic	   field,	   introducing	   local	   inhomogeneities	   that	  expedite	  T2*	  relaxation.	  SPIOs	  have	  relatively	  little	  effect	  on	  T1	  relaxation	  and	  thus	  MR	  imaging	  in	  this	  study	  focuses	  on	  T2	  characteristics.	  	  
1.1.3	  Forming	  an	  MR	  Image	  Building	   on	   the	   principles	   of	   NMR,	   we	   will	   next	   explore	   how	   this	  phenomenon	  is	  used	  to	  form	  two-­‐dimensional	  MR	  images.	  There	  are	  many	  methods	  to	  acquire	  an	  MR	  image,	  the	  simplest	  of	  which	  is	  a	  Spin	  Echo.	  The	  collection	  of	  a	  FID	  from	   a	   slice	   of	   an	   object	   of	   interest	   requires	   the	   use	   of	   magnetic	   field	   gradients,	  which	  are	  applied	  sequentially	  (Figure	  4).3	  	  




Figure	  4.	  Pulse	   sequence	   to	   generate	  a	   Spin	  Echo	  MR	   image.	  RF	  line	  indicates	  timing	   of	   the	   excitatory	   and	   refocusing	   pulses;	   following	   three	   rows	   describe	  gradient	   encoding	   to	   acquire	   spatially	   localized	   data.	   Recording	   by	   receiver	   coil	  synced	  with	  refocusing	  of	  transverse	  MDM	  to	  acquire	  largest	  signal.3	  	  	   The	  slice-­‐encoding	  gradient	  (Gs)	  is	  used	  to	  change	  the	  net	  magnetic	  field	  in	  a	  slice	  by	  ΔBq,	  giving	  the	  subset	  of	  water	  protons	  within	  a	  unique	  range	  of	  resonance	  frequencies	  (Eqn.	  6).	  	  
∆E   =   hυ   =   γ !!" !! + Δ!! 	   	   	   (Equation	  6)	  A	   soft	   90°	   RF	   pulse	   is	   then	   applied	   to	   excite	   the	   protons	   in	   this	   region	   of	  interest,	  forcing	  them	  to	  precess	  in	  the	  transverse	  plane,	  as	  shown	  in	  Figure	  2.	  Due	  to	  T1	  and	  T2	  relaxation,	  the	  excited	  proton	  MDMs	  will	  begin	  to	  dephase	  and	  revert	  to	  precession	  about	  the	  z-­‐axis	  once	  the	  RF	  pulse	  is	  removed.	  	  A	  180°	   refocusing	  RF	  pulse	   is	   then	  applied	   to	   “flip”	  all	  proton	  MDMs	  about	  the	  transverse	  plane.5	  As	  they	  relax	  back	  towards	  precession	  around	  the	  axis	  of	  the	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  http://www.medical.siemens.com	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external	   magnetic	   field	   and	   begin	   to	   precess	   in	   phase	   once	   again,	   the	   frequency-­‐encoding	  gradient	  (Gf)	  is	  applied	  and	  FID	  signal	  is	  collected	  by	  the	  receiver	  coil	  for	  one	   value	   of	   the	   phase	   encoding	   gradient	   (Gp).	   This	   captures	   the	   “echo”	   of	  transverse	   magnetization,	   and	   the	   peak	   in	   signal	   marks	   the	   echo	   time	   (TE).	  Successive	   echoes	   are	   collected	   at	   different	   values	   of	   Gp;	   the	   duration	   of	   each	  repetition	  of	   the	  pulse	  sequence	   is	  marked	  by	   the	  repetition	   time	  (TR)	  parameter.	  The	  MR	  data	  are	  then	  fourier	  transformed	  to	  acquire	  an	  image.	  In	  summary,	  a	  spin	  echo	  MR	  image	  is	  generated	  using	  slice,	  frequency,	  and	  phase	  encoding	  to	  spatially	  encode	   the	   MR	   signal,	   which	   provides	   the	   spatial	   resolution	   to	   form	   a	   two-­‐dimensional	  MR	  image	  of	  a	  material.	  	  As	  discussed	   in	   the	  previous	   section,	   each	  material	   has	   a	  unique	  T1	   and	  T2	  relaxation	  time	  constant.	  MR	  imaging	  parameters	  are	  weighted	  to	  selectively	  collect	  information	  about	  either	  relaxation	  characteristic.	  This	  study	  uses	  T2-­‐weighting	   to	  capture	   contrast	   enhancement	   by	   SPIO	   NPs.	   A	   long	   TE	   and	   TR	   generate	   a	   T2	  weighted	  MR	  image.	  
1.1.4	  MRI	  with	  Exogenous	  Nanoparticle	  Contrast	  Agents	  	  As	  mentioned	  in	  Section	  1.2,	  iron	  oxide	  NPs	  act	  as	  exogenous	  contrast	  agents	  for	   MRI	   by	   increasing	   magnetic	   field	   inhomogeneity	   and	   thereby	   expediting	  transverse	   relaxation	   of	   neighboring	  water	   protons.	   Like	   proton	  MDMs,	   SPIO	  NPs	  magnetically	  align	  with	  an	  external	  magnetic	  field.7	  Iron	  oxide	  is	  ferromagnetic	  and	  contains	   many	   magnetic	   domains	   that	   remain	   aligned	   after	   the	   removal	   of	   an	  external	  magnetic	  field,	  preserving	  the	  magnetization	  of	  the	  material.	  SPIO	  NPs,	  with	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an	   iron	   oxide	   core	   less	   than	   about	   10	   nm	   in	   diameter,	   have	   only	   one	   magnetic	  domain	   and	   therefore	   very	   different	  magnetic	   properties.	   Each	   SPIO	  NP’s	   domain	  will	  align	  with	  an	  eternal	  magnetic	  field,	  just	  like	  those	  of	  individual	  domains	  within	  bulk	   iron	   oxide	   (Fig.	   5).	   However,	   SPIO	   materials	   will	   revert	   completely	   back	   to	  random	  magnetic	  orientation	  when	  the	  external	  field	  is	  removed,	  unlike	  iron	  oxide	  materials	   greater	   than	   10	   nm,	   which	   retain	   some	   residual	   magnetization.	   Their	  superparamagnetic	   properties	   make	   SPIO	   NPs	   nonmagnetic	   in	   the	   absence	   of	   an	  external	  magnetic	  field,	  a	  key	  attribute	  for	  in	  vivo	  use.	  
	  	  















concentration	  dependent	  decrease	   in	  T2	   time	  of	  a	   sample,	  which	   is	  determined	  by	  collecting	  FIDs	  at	  many	  different	  TEs	  and	  fitting	  the	  recorded	  MT	  signal	  to	  Equation	  5	   (Fig.	   6A).	   A	  molar	   relaxivity	   value,	   r2,	   is	   obtained	   for	   different	   types	   of	   NPs	   by	  graphing	  the	  inverse	  of	  the	  T2	  time	  constant	  versus	  the	  concentration	  of	  iron	  in	  the	  sample,	   which	   is	   proportional	   to	   the	   concentration	   of	   NPs	   (Equation	   7)(Fig.	   6C).	  This	   value	   varies	  with	   the	   composition	   of	  moieties	   attached	   to	   the	   surface	   of	   the	  SPIO	  NP.3	  




Figure	  6.	  Obtaining	  Relaxivity	  values	  for	  silica	  coated	  SPIO	  NPs.	  A)	  Transverse	  MR	  signal	  decay	   shown	  with	   increasing	  echo	   time	   (TE).	  The	   curve	   that	   shows	   the	  least	   decay	   corresponds	   to	   the	   pure	   water	   sample.	   B)	   T2-­‐weighted	   MR	   image	  showing	  the	  cross	  section	  of	  phantom	  containing	  water	  suspensions	  of	  two	  types	  of	  silica	  coated	  NPs	  (type	  1	  and	  2)	  at	  three	  different	  concentrations:	  i:	  1:7.5	  dilution,	  ii:	  1:15	   dilution,	   iii:	   1:30	   dilution.	   Contrast	   achieved	   by	   NPs	   indicated	   by	   image	  darkening	  with	  increased	  concentration.	  Bright	  sample	  on	  far	  left	  is	  nH2O	  control.	  C)	  A	   representative	   plot	   of	   T2	   relaxation	   rate	   (R2;	   s-­‐1)	   versus	   iron	   concentration	   (Fe;	  mM),	   obtained	   by	   ICP-­‐OES.	   The	   slope	   of	   this	   line	   is	   r2,	   or	  molar	   relaxivity	   of	   the	  sample	  of	  NPs.	  	  































afford	  diagnostic	  and	  treatment	  applications.	  The	  r2	  value	  of	  a	  type	  of	  NP	  is	  directly	  proportional	  to	  its	  Magnetic	  polarization	  (M),	  or	  the	  magnitude	  of	  its	  magnetization	  vector	  (Fig.	  7A).	  	  Doping	  SPIO	  NPs	  with	  zinc	  increases	  r2,	  as	  does	  the	  incorporation	  of	  manganese.8,	  9	  Larger	  SPIO	  NPs	  show	  higher	  r2	  values	  both	  in	  vivo	  and	  in	  vitro.10	  Increased	   r2	   enhances	   the	   sensitivity	  of	   SPIO	  NPs	  as	   a	   therapeutic/diagnostic	   tool	  (Fig.	  7B).	  	  
	  









To	   further	   expand	   the	   capabilities	   of	   SPIO-­‐based	   NPS,	   researchers	   have	  tethered	   additional	   components	   to	   the	   surface	   for	  multi-­‐modal	   imaging.8	   Positron	  emitting	  moieties	  allow	  for	  positron	  emission	  tomography	  (PET)	  and	  fluorophores	  afford	   near	   infrared	   fluorescence	   (NIRF)	   spectroscopy	   in	   vivo;	   these	   modalities	  complement	   the	   MRI	   facilitated	   by	   the	   NMR	   active	   SPIO	   core.8	   Attachment	   of	  multiple	  components	  must	  be	  conducted	  using	  orthogonal	  chemistries	  to	  limit	  side	  reactions	  and	  improve	  control.	  This	  functionalization	  chemistry	  is	  divided	  into	  three	  main	   categories:	   peptidic,	   thiol,	   and	   click	   chemistry	   (Fig.	   8).11	   Peptidic	   chemistry	  uses	  the	  peptide	  bond	  to	  fasten	  components	  to	  the	  NP	  surface.	  Thiol	  chemistry	  links	  an	  electron	   rich	  maleimide	   to	   a	   reduced	   thiol	   via	   a	  Michael	   addition.	   Finally,	   click	  chemistry	  connects	  a	  terminal	  azide	  and	  an	  alkyne	  in	  a	  cycloaddition	  reaction.	  
	  	  
Figure	  8.	  Linker	  chemistries	  to	  tether	  functional	  moieties	  to	  the	  surface	  of	  NPs.	  Peptidic	   chemistry	   creates	   a	   peptide	   bond	   to	   connect	   proteins	   to	   the	   NP	   surface;	  thiol	   chemistry	   uses	   a	   Michael	   addition	   to	   a	   maleimide	   to	   create	   a	   sulfur-­‐carbon	  covalent	   bond,	   or	   oxidizing	   conditions	   to	   form	   a	   disulfide	   bond;	   click	   chemistry	  involves	  the	  cycloaddition	  process	  of	  an	  azide	  and	  an	  alkyne.11	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In	  addition	   to	   the	   covalent	   chemistries	  discussed	  above,	   small	  proteins	   can	  also	   be	   used	   to	   attach	   moieties	   in	   an	   orientation-­‐dependent	   manner.	   Bacterially	  derived	   or	   recombinant	   Proteins	   A	   and	   G	   have	   a	   high	   affinity	   for	   the	   fragment	  crystalline	   (Fc)	   region	   of	   immunoglobulin	   antibodies	   and	   can	   be	   used	   to	   achieve	  orientation	  specific	  antibody	  attachment	  for	  immunotargeting.11-­‐13	  Other	  methods	  of	  conjugating	  antibodies	  to	  the	  NP	  surface	  are	  described	  by	  E.	  White	  (2013).14	  These	  diverse	  chemistries	  allow	  NP	  functionalization	  for	  applications	  from	  the	  diagnosis	  to	  treatment	  of	  disease.	  
1.3	  Interaction	  with	  Biological	  Systems	  and	  Toxicity	  There	   is	   a	  myriad	  of	  possibilities	   for	  multifunctional	  SPIO	  NPs	   in	  medicine,	  but	   the	   NPs’	   biocompatibility	   must	   also	   be	   considered	   when	   designing	   a	   viable	  clinical	  product.	  Iron	  oxide	  has	  a	  very	  low	  biological	  toxicity,	  most	  likely	  due	  to	  the	  high	   concentrations	   of	   iron	   carried	   in	   the	   body.11	   LD50	   values	   obtained	   for	   mice,	  rabbits,	  and	  dogs4	  lead	  to	  an	  estimation	  of	  human	  toxicity	  above	  60	  milligrams	  per	  kilogram	  body	  weight.15	  Commercial	  SPIO	  NP	  contrast	  agents,	  used	  in	  the	  clinic	  for	  almost	  twenty	  years,	  are	  routinely	  administered	  below	  1	  mg	  Fe/kg	  body	  weight.	  Various	  parameters	   contribute	   to	   the	  pharmacology	   of	   SPIO	  NPs,	   including	  size,	   coating,	   surface	   charge,	   and	   distribution	   of	   charge.	   For	   non-­‐targeted	  chemotherapeutic	  NPs,	   localization	   to	   tumor	   tissue	   is	  dependent	  on	   the	   enhanced	  permeability	   and	   retention	   (EPR)	   effect,	   which	   is	   due	   to	   the	   increased	  vascularization	   of	   cancerous	   tissue.11	   The	   blood	   half-­‐life	   of	   NP	   therapies	   must	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	  Iron	  oxide	  LD50	  (grams	   iron	  oxide	  per	  kilogram	  body	  weight)	   for	  mouse:	  5	  g/kg;	  rabbit:	  1	  g/kg;	  dog:	  0.7	  g/kg.	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therefore	  be	   long	  enough	   to	  realize	   this	  passive	  accumulation	   in	   the	   tumor,	  which	  typically	  takes	  over	  six	  hours.	  	  The	  body	  has	   two	  primary	  response	  mechanisms	   to	   remove	   foreign	  matter	  such	  as	  NPs:	   the	  renal	   system,	  which	  clears	  particles	   less	   than	  10	  nm	  through	   the	  kidneys,	   and	   the	   innate	   immune	   system,	   which	   uses	   macrophages	   to	   capture	  particles	   greater	   that	   100	   nm	   in	   size	   for	   disposal	   through	   the	   lymph	   system.11	  Macromolecules	  greater	  than	  50	  kDa	  are	  known	  to	  best	  demonstrate	  the	  EPR	  effect,	  but	  are	  also	  typically	  greater	  than	  100	  nm	  in	  size,	  making	  them	  vulnerable	  to	  non-­‐specific	   uptake	   by	   macrophages.	   Building	   multifunctional	   SPIO	   NPs	   targeted	  towards	   cancerous	   tumors	   requires	   balancing	   the	   competing	   factors	   of	   contrast	  capability	  and	  therapeutic	  efficacy.	  	  The	  role	  of	  physical	  characteristics	  of	  NPs	  in	  regulating	  their	  interaction	  with	  the	  body	  has	  been	  extensively	  studied.10,	  16-­‐22	  Particles	  between	  20	  and	  40	  nm	  in	  size	  are	  non-­‐toxic	   to	  macrophage	  and	  tumor	  cells	  at	  concentrations	  up	  to	  200	  μg/ml.10	  For	  particles	  of	  similar	  size	  and	  charge,	  surface	  coating	  dictates	  NP	  interactions	  with	  cells	   and	   proteins.21	   Silica	   coated	   SPIO	   NPs	   do	   not	   stimulate	   the	   secretion	   of	  inflammatory	   cytokines	   or	   disrupt	   mitochondrial	   function	   in	   macrophages	   or	  dendritic	   cells,	   providing	   evidence	   that	   this	   core/shell	   combination	   is	  biocompatible.20	   Polyethylene	   glycol	   (PEG),	   a	   hydrophilic	   polymer,	   effectively	  shields	   SPIO	   NPs	   from	   the	   innate	   immune	   system,	   allowing	   the	   EPR	   effect	   and	  targeting	  moieties	   to	  deliver	   these	  NPs	   to	  malignant	   tissue.17,	  18	   The	  effects	  of	   this	  moiety	  are	  dependent	  on	  the	  length	  of	  PEG	  used,	  where	  a	  hyperbolic	  trend	  describes	  the	  optimal	  PEG	  length,	  with	  5000	  Da	  PEG	  yielding	  the	  most	  stealthy	  particles.17,	  23	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At	  the	  macromolecular	   level,	  NPs	  exposed	  to	  biological	   fluids	  adsorb	  serum	  proteins,	  which	  form	  a	  protein	  corona	  whose	  composition	  and	  kinetics	  of	  formation	  have	   been	   computationally	   and	   experimentally	   explored.	   Del’Orco	   and	   colleagues	  (2010)	   used	   experimentally	   derived	   parameters	   to	   model	   the	   kinetics	   of	   corona	  formation	  on	  NPs	   in	  blood.24	  The	  model	  accounted	  for	  the	  binding	  of	   three	  critical	  blood	  proteins:	  high-­‐density	   lipoprotein	   (HDL),	  human	   serum	  albumin	   (HSA),	   and	  fibrinogen.24	  These	  researchers	  concluded	  that	  the	  70	  nm	  polymer-­‐based	  NPs	  tested	  take	   four	   to	   twenty-­‐eight	   hours	   to	   acquire	   a	   stable	   corona	   when	   delivered	  intravenously	  and	  exposed	  to	  this	  cocktail	  of	  proteins	  in	  the	  blood.	  Implementation	  of	   this	  simple	  model	   for	  other	  systems	  would	   facilitate	  a	  greater	  understanding	  of	  the	  physiological	  interactions	  that	  may	  determine	  the	  efficacy	  of	  NP	  therapeutics.	  Cellular	   internalization	   is	   another	   critical	   component	   of	   therapeutic	   NP	  delivery	  and	  depends	  strongly	  on	  the	  magnitude	  and	  spatial	  distribution	  of	  charge	  on	   the	   NP	   surface.21	   The	   cell	   membrane	   is	   negatively	   charged,	   and	   thus,	   by	  Coulomb’s	  Law,	  highly	  positively	  charged	  NPs	  should	  be	  most	  effective	  at	  generating	  binding	  events.	  However,	  NPs	  encounter	  many	  other	  potential	  binding	  “partners”	  en	  route	   to	   the	   target	   tissue	   and	   exposed	   positive	   charges,	   such	   as	   primary	   amines,	  increase	  non-­‐specific	  binding,	  inhibiting	  effective	  NP	  delivery	  (Fig.	  9A).	  In	  addition,	  exposed	  charges	  stimulate	  the	  formation	  of	  a	  more	  extensive	  protein	  corona	  around	  NPs,	   further	   impeding	   tissue	   targeting.11,	   22	   Negatively	   charged	   particles	   are	  identified	  and	  cleared	  by	  the	  spleen,	  reducing	  circulation	  time	  for	  NPs	  to	  find	  their	  target	  tissue.	  This	  evidence	  points	  to	  neutral	  NPs	  as	  the	  ideal	  for	  targeted	  therapies,	  However,	  Townson	  and	   colleagues	   (2013)	   found	   that	   obstructed	  positive	   charges.	  
Nagalla	  2014	  
23	  
protected	  by	  larger	  PEG	  molecules,	  can	  produce	  strong	  binding	  and	  internalization	  while	  minimizing	  non-­‐specific	  uptake	  (Fig.	  9B).11,	  21	  	  
	  
Figure	  9.	  Spatial	  arrangement	  of	  charges	  on	  the	  NP	  surface	  determine	  cellular	  
internalization.	  A)	  Exposed	  primary	  amines	  on	  polyethylene	  imine	  (PEI)	   increase	  non-­‐specific	  uptake.	  B)	  Amines	   shown	   in	  blue	  are	   shielded	  by	  polyethylene	  glycol	  (PEG)	  and	  show	  strong	  tissue	  targeting	  when	  functionalized	  with	  targeting	  moiety,	  with	  limited	  non-­‐specific	  internalization.20	  	   The	  effect	  of	  NPs	  on	  body	  tissues	  is	  known	  to	  vary.11,	  22	  Internalization	  of	  iron	  oxide	  NPs	  may	  alter	  cell	   fate,	  but	   that	   impact	   is	  cell-­‐type	  specific.11	  Tissue	  specific	  targeting	   is	   therefore	  particularly	   apt	   for	   this	   therapeutic	  modality	   and	  allows	   for	  treatment	  and	  monitoring	  of	  metastatic	  disease	  in	  addition	  to	  primary	  tumors.	  	  




1.4	  Project	  Overview	  This	  thesis	  work	  focuses	  on	  building	  multifunctional	  silica-­‐coated	  iron	  oxide	  nanoparticles	  for	  imaging	  and	  targeted	  cancer	  therapy.	  The	  silica	  shell	  disguises	  the	  NPs	   from	   the	   body’s	   innate	   immune	   system	   and	   affords	   easy	   attachment	   of	  treatment	   and	   targeting	   components.	   The	   adaptability	   of	   these	   nanoparticles	   in	   a	  “plug	  and	  play”	  model	  makes	   them	   ideal	   for	   targeted	   cancer	   therapy.	  This	  project	  aims	  to	   integrate	   imaging	  and	  targeting	  modalities	  and	  optimize	  the	  detection	  and	  tracing	  of	  these	  NPs	  in	  tissue	  using	  MRI.	  Proton	  magnetic	  resonance	  imaging	  (MRI)	  is	  employed	  in	  this	  study	  to	  quantify	  the	  T2	  contrast	  enhancement	  achieved	  by	  SPIO	  NPs	   in	   agarose	   suspension.	   Endocytosis	   of	   NPs	   is	   evaluated	   by	   attaching	   a	   pH	  dependent	  fluorophore	  to	  the	  silica	  surface	  and	  imaging	  treated	  cells	  using	  confocal	  microscopy.	  
	   	  
Nagalla	  2014	  
25	  
2	  Materials	  and	  Methods	  
2.1	  Building	  Multifunctional	  Silica-­‐Coated	  SPIO	  NPs	  2.1.1	  Silica	  coating	  of	  SPIO	  NPs	  (ME12)	  Silica-­‐coating	   of	   FerrotecTM	   SPIO	  NPs	   	   and	   subsequent	   characterization	   via	  MRI,	  ICP-­‐OES,	  and	  TEM	  was	  performed	  by	  Alice	  Liao	  (Wellesley	  College	  ’15).25	  	  
2.1.2	  Conjugation	  of	  Antibody	  to	  NP	  
2.1.2.1	  Thiolation	  of	  Antibody	  for	  Attachment	  to	  PEG-­‐silane	  Linker	  Samples	   of	   human	   IgG	   purified	   from	   plasma	   (Athens	   Research	   and	  Technology)	   and	   monoclonal	   antibody	   31.1	   (Andrew	   Webb)	   were	   concentrated	  using	   a	   VirTis	   Sentry	   3L	   lyophilizer	   and	   thiolated	   using	   Traut’s	   reagent,	   2-­‐iminothiolane•HCl	   (Thermo	   Scientific	   26101)	   according	   to	   manufacturer’s	  specifications.	  Thiolated	  antibodies	  were	   isolated	  using	  a	  7k	  MWCO	  desalting	  spin	  column	   (Thermo	   Scientific	   89892;).	   Absorbance	   at	   280	   nm,	   measured	   using	   the	  NanoDrop	  spectrophotometer,	  confirmed	  the	  recovery	  of	  IgG.	  	  	  
2.1.2.2	  Sulfhydryl	  Quantification	  via	  Ellman’s	  Reagent	  The	   number	   of	   thiol	   groups	   per	   antibody	   was	   assessed	   using	   Ellman’s	  reagent,	   5,5'-­‐dithiobis-­‐(2-­‐nitrobenzoic	   acid)	   (Thermo	   Scientific	   22582)	   (Fig.	   10).	  Solutions	   of	   0-­‐1.5	  mM	   cysteine•HCl•H2O	   (Pierce	   44889)	  were	   used	   to	   generate	   a	  standard	   curve	   for	   quantification	   of	   thiols	   with	   this	   colorimetric	   indicator.	  Manufacturer’s	  protocol	  was	  optimized	  for	  a	  28	  μl	  scale	  assay,	  using	  5	  μl	  thiolated	  protein,	   3	   μl	   3.3	   mM	   Ellman’s	   reagent,	   and	   20	   μl	   0.1	   M	   pH	   8	   sodium	   phosphate	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buffer	   chelated	   with	   1	   mM	   EDTA.	   NanoDrop,	   Cary	   50,	   and	   Molecular	   Devices’	  SpectraMax	  190	  UV-­‐Visible	   spectrophotometers	  were	  used	   to	  measure	  absorption	  of	  the	  reaction	  product	  at	  412	  nm	  for	  each	  sample.	  The	  SpectraMax	  190	  instrument	  produced	   the	  most	  precise	   results	  while	   requiring	  only	   a	   4	   μl	   volume	  and	   thus	   is	  optimal	  for	  reading	  this	  assay	  (see	  section	  3.2.2).	  
	  
Figure	  10.	  Schematic	  of	  thiolation	  of	  primary	  amine	  via	  2-­‐iminothiolane.	  	  
2.1.2.3	  Conjugation	  of	  Protein	  to	  Mal-­‐PEG-­‐Silane	  Linker	  and	  to	  NP	  Thiolated	  antibody	  was	  coupled	  to	  Maleimide-­‐PEG-­‐Silane	  overnight	  at	  4	  °C	  in	  a	   1:10	  molar	   ratio.	   Unconjugated	   polymer	  was	   removed	   using	   a	   7	   kDa	  molecular	  weight	   cut	   off	   desalting	   column	   (Pierce)	   per	  manufacturer’s	   protocol.	   The	   linker-­‐antibody	  complex	  was	  tethered	  to	  the	  silica	  coated	  SPIO	  in	  NP	  excess	  the	  following	  day	  for	  24	  hours	  before	  purification.	  Fully	  conjugated	  NPs	  were	  collected	  by	  magnet	  and	  washed	  twice	  with	  PBS.	  












2.2	  Characterization	  of	  NPs	  2.2.1	  NP	  Relaxivity	  via	  ICP-­‐OES	  and	  MRI	  MRI	   contrast	   capability	   of	   SPIO	   NPs	   was	   evaluated	   by	   obtaining	   a	   molar	  relaxivity	  value	  for	  the	  material,	  the	  slope	  of	  the	  plot	  of	  1/T2	  relaxation	  time	  against	  iron	  concentration	  (Fig.	  6	  Section	  1.1.4).	  The	   iron	   concentration	   of	   stock	  NPs	  was	   determined	   via	   ICP-­‐OES.	   Samples	  were	  digested	  overnight	  in	  aqua	  regia	  (1:1	  w/v;	  OmniTrace	  Ultra	  (Fisher	  Scientific),	  diluted	   to	   2%	  nitric	   acid,	   and	   filtered	   through	   a	   0.2	  mm	  HT	  Tuffryn	   syringe	   filter	  (Acrodisc)	  prior	  to	  analysis.	  Iron	  (40,	  4,	  .4,	  .04,	  .004	  ppm)	  and	  gold	  standards	  (100,	  10,	  1,	  0.1,	  0.01,	  0.001	  ppm)	  (Sigma	  Aldrich)	  were	  prepared	  in	  2%	  nitric	  acid	  (Fisher	  Scientific)	  and	  used	  to	  generate	  the	  standard	  curves	  for	  experimental	  determination	  of	   iron	   and	   gold	   concentrations	   in	   the	   NP	   samples.	   Optical	   measurements	   were	  taken	  at	  267.6	  nm	  and	  238.2	  nm	   to	  determine	   the	   concentration	  of	   gold	   and	   iron	  respectively	  using	  an	  Optima	  7000	  DV	  ICP-­‐OES	  spectrometer.	  T2	   relaxation	   time	   constants	   for	   serial	   dilutions	   of	   the	  NPs	   (0.3,	   0.15,	   0.07,	  0.04	  mM	  iron)	  were	  determined	  by	  collecting	  MRI	  data	  at	  serial	  dilution	  values	  of	  TE	  for	  NPs	  in	  agarose	  suspension.	  MR	  images	  of	  NP	  samples	  in	  water,	  agarose,	  and	  cell	  suspension	  were	  collected	  using	  a	  400	  MHz	  Bruker	  Avance	  NMR	  spectrometer	  (9.4	  T,	  2.4	  G/cm/A	  gradient	  strength,	  vertical	  bore).	  For	  agarose	  suspension,	  NP	  samples	  were	  mixed	  with	  molten	  2%	  w/v	  agarose,	  in	  a	  37	  °C	  walk	  in	  incubator,	  transferred	  to	  separate	  7-­‐inch,	  3	  mm	  diameter	  NMR	  tubes	  (Wilmad	  Glass)	  and	  allowed	  to	  set	  at	  room	  temperature	  for	  one	  hour.	  Cells	  treated	  with	  NPs	  were	  suspended	  in	  agarose	  for	  imaging	  in	  the	  same	  manner.	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A	   custom	   sample	   holder	   (built	   by	   Stephanie	   Huang,	  Wellesley	   College	   ’12)	  was	   used	   to	   suspend	   these	   samples	   in	   the	   bore	   of	   the	   magnet	   for	   imaging.	   A	  maximum	  of	  7	  NP	  samples	  were	  image	  at	  one	  time.	  Tuning	  and	  matching	  was	  first	  conducted	  manually,	  followed	  by	  an	  auto	  tuning	  and	  matching	  tripilot	  scan	  using	  the	  shim	   file	   “JRSHNPP”	   (created	   by	   Jasmine	   Rana,	   Wellesley	   College	   ’12).	   This	  preparatory	   scan	   generated	   two	   images	  with	   axial	   orientation	   and	   one	   in	   sagittal	  view	  (Fig.	  11).	  Paravision	  4.0	  software’s	  “MSME-­‐T2-­‐map”	  pulse	  sequence	  was	  used	  to	  generate	  the	  MR	  images	  for	  analysis	  and	  consisted	  of	   the	  following	  parameters:	  FOV	  of	  4	  x	  4	  cm	  with	  0.5	  mm	  slice	  thickness;	  TR	  =	  3062	  sec;	  TE	  =	  10	  -­‐	  600	  ms	  at	  10	  ms	   intervals;	   60	   echoes,	   1	   average,	   128	   x	   128	   matrix.	   Acquisition	   required	  approximately	  9.5	  min	  and	  generated	  three	  axial	  images	  (Fig.	  11B).	  	  
	  
Figure	   11.	  MR	   images	   from	  Tripilot	   scan	   JRSHNPP.	  A)	  Sagittal	   image,	   showing	  length	  of	  NMR	   tube	   containing	  agarose	   suspension.	  B)	  Axial	   image,	   taken	  midway	  along	  the	  NMR	  sample	  tube,	  showing	  5	  samples	  in	  phantom	  holder.	  Using	   the	   image	   sequence	   analysis	   (ISA)	   tool	   in	   Paravision	   4.0,	   a	   3	   mm	  diameter	  region	  of	  interest	  (ROI)	  was	  selected	  for	  each	  sample.	  The	  decay	  of	  signal	  intensity	  within	  the	  ROI	  for	  each	  sample	  (Fig.	  6,	  Section	  1.1.4)	  was	  fit	  to	  Equation	  7	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to	  obtain	  T2	  values	  for	  each	  sample.	  1/T2	  values	  were	  plotted	  against	  concentration	  of	  iron	  in	  each	  sample	  to	  determine	  the	  r2	  values	  of	  ME11	  and	  ME12	  NPs.	  	  
2.2.2	  Infrared	  Spectroscopy	  A	   Bruker	   alpha	   Pt	   attenuated	   total	   reflectance-­‐fourier	   transform	   infrared	  (ATR-­‐FTIR	  )	  spectrometer	  was	  used	  to	  detect	  silica	  coating	  and	  PEGylation.	  Spectra	  of	   silica	   coated,	   PEGylated,	   SPIO	   NPs	   and	  mixtures	   of	   mPEG-­‐silane	   and	  Mal-­‐PEG-­‐silane	   were	   collected	   and	   analyzed.	   NP	   samples	   were	   prepared	   by	   drying	   water	  suspensions	  of	  NPs	  in	  a	  chemical	  fume	  hood.	  PEG	  mixtures	  were	  prepared	  in	  ratios	  of	   1:1	   and	   2:1	   in	   ethanol	   at	   0.01	   mg/μl	   and	   then	   dried	   for	   three	   days	   before	   IR	  analysis.	   The	   following	   instrument	   parameters	   were	   used	   to	   collect	   spectra:	   a	   4-­‐acquisition	   background	   scan;	   256	   acquisitions	   per	   sample	   at	   1	   cm-­‐1	   resolution;	  spectra	  collected	  over	  500-­‐4000	  cm-­‐1	  range.	  OPUS	  7.0	  software	  and	  Microsoft	  Excel	  were	  used	  to	  display	  and	  analyze	  spectra.	  
2.2.3	  TEM	  (Protocol	  in	  Appendix	  IA)	  Imaging	   of	   NPs	   using	   Transmission	   Electron	   Microscpoy	   (TEM)	   was	  conducted	   on	   the	   JEOL	   TEM	   at	   Harvard	   Medical	   School	   to	   gauge	   NP	   size	   and	  morphology.	  NPs	  were	  mounted	  on	  Formvar	  carbon	  grids	  with	  SiO	  lattice	  fringes	  by	  inverting	   the	   grids	   onto	   a	   droplet	   of	   undiluted	   NPs	   from	   the	   synthesis,	   allowing	  them	   to	   adhere.	   These	   grids	  were	   then	   dried	   overnight	   and	   subsequently	   imaged	  using	  a	  tungsten	  filament	  JEOL	  TE	  microscope	  under	  the	  following	  parameters:	  80,	  100	  kV,	  40,000-­‐150,000x	  magnification.	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2.2.4	  PEG	  Assay	  A	  96-­‐well	  format	  barium	  chloride,	  iodine	  assay	  for	  PEG	  optimized	  by	  Harini	  Natarajan	   (Wellesley	   College	   ’15)	   was	   conducted	   using	   serially	   diluted	   standard	  solutions	  of	  5	  kDa	  methoxyPEG	   (mPEG)(0-­‐10	  mg/ml)	   to	   find	   the	   concentration	  of	  PEG	   in	   the	   NP	   sample.26	   1/50	   and	   1/100	   dilutions	   of	   sample	   were	   analyzed	   to	  ensure	  PEG	  concentrations	  in	  the	  appropriate	  range.	  
2.2.5	  Chemiluminescent	  Dot	  Blot	  Approximately	   10	   μg	   samples	   of	   protein	   conjugated	   to	   NPs	   were	   spotted	  onto	  a	  nitrocellulose	  membrane	  and	  allowed	  to	  dry	  for	  confirmation	  of	  antibody-­‐NP	  conjugation.	  The	  membrane	  was	  incubated	  on	  a	  rocker	  for	  1	  hour	  in	  blocking	  buffer	  (5	  g	  Bio-­‐Rad	  blotting	  grade	  blocker	   in	   tris	  buffered	  saline	   (TBS)	  and	  0.1%	   tween)	  and	  then	  another	  hour	  in	  the	  presence	  of	  (1:1000	  dilution	  in	  blocking	  buffer)	  anti-­‐biotin	  antibody	  (HRP	  conjugated	  anti-­‐biotin,	  Webb	  Lab).	  The	  unbound	  antibody	  was	  removed	  with	  washing	  buffer	  (0.1%	  tween	  in	  TBS)	  in	  4	  washes.	  The	  membrane	  was	  then	  dabbed	  dry	  and	  sprayed	  with	  HyGloTM	  Quickspray	  luminol/peroxide	  solution,	  then	  visualized	  using	  the	  Bio-­‐Rad	  “chemiluminescent	  blot”	  program	  on	  the	  Bio-­‐Rad	  Imaging	  System.	  Protocol	  adapted	  from	  the	  Webb	  Lab.	  
2.2.6	  Characterizing	  Amine-­‐Reactive	  pHrodo-­‐Green	  Fluorophore	  Absorbance	  and	  fluorescence	  spectra	  of	  pHrodo-­‐green	  (Life	  Technologies)	  in	  solutions	   of	   varying	   pH	   were	   collected	   using	   Molecular	   Devices	   SpectraMax	   M3	  microplate	  spectrophotometer.	  Known	  pH	  solutions	  (pH	  2-­‐8)	  were	  prepared	  using	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HCl	  and	  NaOH.	  Solutions	  were	  loaded	  into	  96-­‐well	  clear	  bottom	  fluorescence	  plate	  (Corning	   Costar	   3603).	   Because	   pHrodo-­‐Green	   did	   not	   remain	  well	   suspended	   in	  aqueous	  solution	  for	  over	  ten	  minutes,	  frequent	  vortexing	  was	  necessary	  to	  achieve	  uniform	   aliquots.	   Spectrophotometer	   was	   operated	   according	   to	   protocol	   in	  instrument	   manual	   to	   instrument	   under	   the	   following	   parameters:	   Absorbance	  spectra	   400-­‐600	   nm	   with	   10	   nm	   steps	   were	   collected	   after	   auto-­‐mixing	   for	   5	  seconds;	  Fluorescence	  spectra	  were	  collected	  using	  490	  nm	  excitation	  and	  the	  same	  spectral	   parameters	   as	   for	   absorbance	   measurements.	   Precision	   was	   set	   to	   7	  reads/well	  and	  PMT	  sensitivity	  to	  automatic;	  other	  settings	  were	  left	  at	  default.	  The	  samples	  were	  auto-­‐mixed	  once	  before	  starting	  data	  collection.	  
2.3	  In	  Vitro	  Studies	  of	  NPs	  (Protocols	  in	  Appendices	  IB-­‐IE)	  2.3.1	  Cell	  Culture	  and	  Treatment	  	  (adapted	  from	  cell	  culture	  protocol	  in	  the	  Webb	  lab)	  CAPAN-­‐2	  and	  BxPC3	  cells	  were	  maintained	  in	  T-­‐25	  flasks	  suspended	  in	  RPMI	  complete	   media	   (Sigma	   Aldrich).	   Cells	   were	   seeded	   on	   #1.5	   glass	   cover	   slips	  (Corning)	   at	   a	   density	   of	   100,000	   or	   50,	   000	   cells	   per	   well	   in	   6-­‐well	   cell	   culture	  plates	   (Falcon).	   These	   cultures	   were	   incubated	   at	   37°	   C,	   5	   %	   CO2	   until	  approximately	   65%	   confluent	   at	   which	   time	   treatment	   was	   initiated.	   Cells	   were	  washed	   once	   with	   room	   temperature	   PBS	   and	   then	   treated	   for	   90	   minutes	   with	  As33@pHrodo	  (4	  and	  10	  μg/ml).	  Post	  treatment,	  cells	  were	  washed	  twice	  with	  PBS	  and	   then	   fixed	   and	   mounted	   for	   visualization	   as	   per	   the	   immuno	   fluorescence	  protocol	  described	  in	  Appendix	  IC.	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2.3.2	  Confocal	  Microscopy	  	  Cellular	   internalization	  was	  detected	  using	  a	  Leica	  SP5	  confocal	  microscope	  equipped	  with	   488	   Argon	   and	   405	   diode	   lasers	   (for	   pHrodo	   and	   DAPI	   excitation	  respectively),	   in	  addition	   to	  a	  broad	  spectrum	  metal	  halide	   light	  source.	  For	  DAPI,	  emitted	   light	  430-­‐550	  nm	  was	  collected;	   for	  pHrodo-­‐Green,	   emitted	   light	  between	  515	  and	  600	  nm	  was	  collected.	  Quantum	  yield	  of	  pHrodo	  was	  higher	  than	  for	  Dapi,	  and	  corresponding	  adjustments	  were	  made	  to	  gain	  and	  offset	  settings	  when	  imaging.	  The	  pinhole	  was	  set	  between	  1	  and	  8	  AU	  depending	  on	  the	  fluorophore	  and	  sample.	  Three	   frame	   averages	   were	   taken	   per	   image	   and	   resolutions	   from	   512x512	   to	  1024x1024	   pixels	   were	   used.	   Vertical	   image	   stacks	   were	   collected	   using	   twenty	  steps	  between	  top	  and	  bottom	  of	  detectable	  fluorophore	  (approximately	  25	  μm).	  	  In	   vitro	   fluorescence	   was	   also	   detected	   using	   Nikon	   80i	   fluorescence	  microscope,	  with	  broad	  spectrum	  metal	  halide	  lamp	  excitation.	  Preset	  DAPI	  settings	  in	  Nikon	  software	  NIS	  ELTs	  were	  used	  to	  capture	  DAPI	  fluorescence.	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3	  Results	  and	  Discussion	  This	  project	  optimized	  new	  techniques	  to	  functionalize	  silica-­‐coated	  SPIO	  NPs	  to	  achieve	  tissue	  targeting.	  The	  following	  goals	  were	  achieved:	  	  
♦ A	  framework	  was	  developed	  to	  detect	  multifunctionalization	  of	  SPIO	  NPs	  via	  IR	  spectroscopy.	  	  
♦ Immunotargeting	  was	  explored	  using	  a	  stochastic	  thiol	  linkage	  to	  conjugate	  antibodies	  to	  the	  NP	  surface.	  	  	  
♦ Directionally	  specific	  attachment	  was	  performed	  via	  recombinant	  protein	  A/G,	  whose	  high	  affinity	  for	  the	  constant	  portion	  of	  immunoglobulins	  allows	  for	  indirect,	  precise,	  NP-­‐Antibody	  assembly.	  	  
♦ A	  cellular	  assay	  was	  developed	  to	  test	  MRI	  detection	  in	  vitro,	  using	  commercially	  available	  gold-­‐coated	  SPIO	  NPs	  conjugated	  with	  targeting	  antibody.	  	  
♦ Tissue	  specific	  targeting	  and	  the	  mechanism	  of	  cellular	  NP	  internalization	  were	  studied	  by	  attaching	  the	  pH	  dependent	  pHrodo-­‐Green	  fluorophore	  to	  targeting	  antibody	  As33	  and	  observing	  endocytosis	  via	  confocal	  microscopy.	  	  	  The	   discussion	   below	   expands	   on	   the	   results	   of	   building	   multifunctional	  silica-­‐coated	  SPIO	  NPs	  and	  assessing	   their	  efficacy	  as	  contrast	  agents	  and	  vehicles	  for	  targeted	  intracellular	  chemotherapy.	  
3.1	  Construction	  of	  Silica-­‐Coated	  SPIO	  NPs	  The	  silica-­‐coated	  SPIO	  NPs	  used	  in	  this	  study	  were	  synthesized	  by	  Alice	  Liao	  (Wellesley	   College	   ’15)	   by	   coating	   12	   nm	   Ferrotec	   SPIO	   cores	  with	   a	   10	   nm	   SiO2	  shell	   in	   a	  microemulsion	   synthesis	   adapted	   from	  Narita	   et	   al	   2009	   and	   the	   thesis	  work	  of	  Jasmine	  Rana	  (Wellesley	  College	  ’12).6,	  25,	  27	  Smaller	  particles	  have	  a	  higher	  surface	  area	   to	  volume	  ratio	  and	   thus	  possess	  a	  higher	   loading	  capacity	   for	  PEG.28	  The	  silica-­‐coated	  SPIO	  NPs	  used	  in	  this	  study	  were	  30	  nm	  in	  diameter	  on	  average,	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allowing	   for	   dense	   surface	   loading	   and	   thus	   potent	   therapy.	   These	   NPs	   were	  characterized	   via	   MRI	   and	   ICP-­‐OES	   as	   described	   in	   section	   1.1.4	   and	   found	   to	  possess	   a	   molar	   relaxivity	   of	   176.1	   mM-­‐1	   s-­‐1.	   This	   value	   surpasses	   the	   bar	   of	  commercially	  available	  contrast	  agents	  (Ferridex	  100	  mM-­‐1	  s-­‐1,	  Resovist	  151	  mM-­‐1	  s-­‐
1)	  and	  indicates	  the	  viability	  of	  this	  type	  of	  NP	  as	  a	  multifunctional	  contrast	  agent.6,	  8	  NPs	  were	  stored	  in	  ethanol,	  then	  dried	  and	  resuspended	  in	  nanopure	  water	  to	  allow	  for	  functionalization	  and	  characterization	  in	  aqueous	  solvent.	  The	   relaxivity	   of	   commercially	   available	   GoldMag	   Dextran	   NPs	   (GoldMag	  Nanobiotech	  Co.)	  was	  also	  obtained	  to	  determine	  their	  contrast	  capability	  and	  found	  to	  be	  292	  mM-­‐1	  s-­‐1.	  These	  particles,	  which	  consist	  of	  gold-­‐coated	  SPIO	  NPs	   further	  functionalized	   with	   a	   shell	   of	   carbohydrate,	   are	   over	   100	   nm	   in	   diameter.29	   T2-­‐weighted	  MR	   images	  were	   collected	   for	   four	   agarose	   suspensions	   of	   these	  NPs	   at	  varying	  concentrations	  (Fig.	  12A).	  	  
	  









Relaxivity	   was	   determined	   as	   outlined	   in	   Section	   1.1.4,	   using	   transverse	  signal	   intensity	   values	   from	   MRI	   (Fig.	   6A,	   13A)	   and	   iron	   concentrations	   of	   each	  sample,	  determined	  by	  ICP-­‐OES	  (Fig.	  6C	  13A).	  The	  observed	  molar	  relaxivity	  value	  of	  GoldMag	  Dextran	  (r2	  =	  292	  s-­‐1	  mM-­‐1)	  is	  strikingly	  high	  in	  comparison	  to	  that	  of	  the	  silica	  coated	  SPIO	  NPs	  used	   in	   this	  project	   (r2	  =	  176	  s-­‐1	  mM-­‐1)	   (Figure	  13C).30	  The	  disparity	   in	  contrast	  capability	  of	   these	  NPs	  may	  be	  explained	  by	  the	  difference	   in	  NP	   core	   size	   (size	   of	  GoldMag	  Dextran	   core	   is	   unknown),	   or	   by	   the	   filtration	   step	  prior	  to	  ICP-­‐OES.	  GoldMag	  Dextran	  NP	  samples	  were	  filtered	  to	  remove	  aggregates	  prior	   to	   ICP-­‐OES	   iron	   concentration	   determination	   and	   thus	   underestimated	   the	  iron	  concentration	   in	   imaged	  NP	  solutions,	  producing	  an	  artificially	  high	  relaxivity	  value.	  In	  the	  future,	  samples	  will	  be	  filtered	  prior	  both	  MRI	  and	  ICP-­‐OES	  to	  eliminate	  this	  source	  of	  error.	  




Figure	   13.	   Iron	   and	   gold	   concentration	   measurement	   and	   relaxivity	  
determination	  of	  GoldMag	  Dextran	  NPs.	  Solutions	  of	  A)	  Iron	  (40,	  4,	   .4,	   .04,	   .004	  ppm)	  and	  B)	  gold	  standards	  (100,	  10,	  1,	  0.1,	  0.01,	  0.001	  ppm)	  were	  used	  to	  generate	  standard	   curves	   for	   ICP-­‐OES	   determination	   of	   iron	   concentration	   in	   the	   four	   NP	  samples	  imaged	  using	  MRI	  (Fig,	  1A).	  C)	  The	  molar	  relaxivity	  of	  GoldMag,	  r2	  =	  292	  s-­‐1	  mM-­‐1,	   is	   the	   proportionality	   constant	   of	   the	   linear	   regression	   fit	   to	   the	   plot	   of	   T2	  relaxation	   rate	   for	   each	   NP	   sample	   against	   its	   unique	   iron	   concentration	   as	  determined	  by	  ICP-­‐OES.	  Zhang	   and	   colleagues	   (2011)	   characterized	   uncoated	   GoldMag	   NPs	   to	  determine	   concentrations	   necessary	   to	   achieve	   contrast;	   these	   scientists	   found	   a	  lower	   limit	   of	   3	  ug/ml	   to	  detect	   contrast	   in	  water	   suspension.31	   GoldMag	  Dextran	  NPs	   too,	   have	   shown	   the	   capability	   to	   act	   as	   effective	   contrast	   agents	   in	   cell	   free	  environments.	  While	  much	  larger	  than	  the	  silica-­‐coated	  SPIO	  NPs	  functionalized	  in	  this	  study,	  at	  over	  100	  nm,	  GoldMag	  Dextran	  NPs	  are	  viable	  as	  T2	  contrast	  agents.	  Gold-­‐coated	  SPIO	  NPs	  thus	  served	  as	  comparable	  substitutes	  for	  silica-­‐coated	  SPIO	  NPs	  when	  optimizing	  cellular	  assays	  of	  MRI	  detection.6	  







































































3.2	  Functionalization	  of	  Silica-­‐Coated	  SPIO	  NPs	  3.2.1	  Functionalization	  with	  PEG	  	  PEG	   confers	   NPs	   with	   biostability,	   hydrophilicity,	   and	   reduced	   immune	  response	   and	   is	   thus	   ubiquitous	   in	   NP	   functionalization.	   PEG	   with	   a	   molecular	  weight	  of	  5	  kDa	  was	  chosen	   in	   this	  study	  as	  a	  “Goldilocks”	   length	  to	  maximize	  the	  benefits	   listed	   above	   while	   also	   optimizing	   SPIO	   contrast	   capabilities	   and	  minimizing	   non-­‐specific	   cellular	   uptake.8,	   10,	   23	   FTIR	   spectroscopy	   was	   used	   to	  determine	  the	  composition	  of	  mixtures	  of	  mPEG-­‐silane	  and	  Mal-­‐PEG	  silane	  as	  a	  first	  step	  towards	  detecting	  and	  characterizing	  multifunctionalization	  of	  NPs.	  	  Each	  type	  of	  PEG	  linker	  appears	  to	  have	  a	  distinct	  IR	  spectrum	  between	  500	  and	  4000	  cm-­‐1	  (Fig.	  14).	  	  A	  sharper	  sp3	  carbon-­‐hydrogen	  peak	  at	  around	  2900	  cm-­‐1	  and	  silica-­‐oxygen	  stretch	  at	  1085	  cm-­‐1	  appear	  in	  the	  Mal-­‐PEG-­‐silane	  spectrum,	  along	  with	  a	  clear	  carbonyl	  peak	  at	  1710	  cm-­‐1.	  Sharper	  signatures	  reflect	  more	  restricted	  vibrational	  motions,	  as	  present	  in	  the	  oscillatory	  carbonyl	  stretch,	  whereas	  broader	  features	  indicate	  less	  constrained	  motions,	  and	  greater	  intermolecular	  forces.	  




Figure	  14.	  Distinct	  FTIR	  spectra	  of	  A)	  mPEG	  silane	  and	  B)	  Mal-­‐PEG-­‐silane	  and	  
their	   chemical	   structures.	   Relevant	   peaks	   are	   labeled	  with	   their	   corresponding	  vibrational	   motions.	   Spectra	   from	   500	   to	   1000	   cm-­‐1	   reflect	   the	   average	   of	   256	  acquisitions.	  	  Jasmine	  Rana	  (2012)	  found	  similar	  signatures	  in	  IR	  spectra	  of	  mPEG-­‐silane.6	  Compared	   side	  by	   side,	   these	   three	  peaks	  distinguish	  mPEG-­‐silane	   from	  Mal-­‐PEG-­‐silane,	   either	   by	   their	   shape	  or	   their	  magnitude.	   (Table	   1).	   Experiments	   by	  Cauda	  and	  colleagues	  (2010)	  describe	  the	  unique	  FTIR	  spectra	  of	  PEGylated	  mesoporous	  silica	  NPs	  coated	  with	  silane	  PEG	  of	  different	  lengths,	  providing	  further	  support	  for	  the	  use	  of	  IR	  to	  identify	  moieties	  on	  the	  NP	  surface.32	  
Table	  1.	  Differential	  IR	  signatures	  of	  Mal-­‐PEG-­‐Silane	  and	  mPEG-­‐Silane.	  Samples	  of	   5	   kDa	   PEG	   of	   each	   type	  were	   analyzed	   by	   FTIR	   spectroscopy.	   256	   acquisitions	  were	  performed	  per	  sample	  and	  averaged	  data	  was	  analyzed.	  	  



































IR Signature? Wavenumber (cm-1)? Mal-PEG-Silane? mPEG-Silane?
sp3 C-H stretch? 2900? Sharp? Broad?
C=O stretch? 1710? Present? Absent?
Si-O stretch? 1080? Sharp? Broad?
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Figure	  15.	   IR	  spectra	  differentiate	  Mal-­‐PEG-­‐Silane	  and	  mPEG-­‐Silane	  mixtures	  











test	   the	  viability	  of	  a	   thiol	   linkage	  between	  a	  maleimide	  (Mal-­‐)	   functionalized	  PEG	  linker	  molecule	  and	  a	  thiolated	  antibody.	  	  Immunoglobulin	   G	   (IgG)	   was	   thiolated	   using	   Traut’s	   reagent	   (2-­‐iminothiolane)	   at	   a	   1:10	   ratio.	   A	   colorimetric	   quantification	   of	   sulfhydryl	   groups	  using	   a	   cysteine•HCl	   standard	   curve	   was	   used	   to	   optimize	   conjugation	   to	  approximately	   one	   Mal-­‐PEG	   linker	   per	   antibody	   (Fig.	   16).	   Standard	   solutions	  showed	   non-­‐linear	   variation	   in	   the	   absorbance	   at	   412	   nm,	   reflected	   by	   a	   poor	  correlation	  coefficient.	  This	  variation	  may	  be	  an	  artifact	  of	  the	  spectrometer	  used	  to	  read	  the	  solutions,	  and	  based	  on	  the	  concavity	  of	  the	  data,	  thiolation	  estimates	  from	  a	   linear	   fit	   to	   absorbance	   values	   of	   the	   standard	   solutions	   may	   be	   taken	   as	   an	  underestimate.	  The	  extent	  of	  thiolation	  exceeded	  expectations,	  resulting	  in	  over	  six	  sulfhydryl	   groups	   per	   antibody,	   as	   estimated	   from	   the	   linear	   fit	   to	   the	   standard	  curve	   (Fig.	   16).	   To	  minimize	   antibody	   conjugation	   to	  more	   than	   two	   PEG	   linkers,	  subsequent	   thiolation	   reactions	   with	   were	   performed	   at	   a	   5:1	   molar	   excess	   of	  Traut’s	  reagent.	  	  




Figure	   16.	   Sulfhydryl	   Quantification	   of	   thiolated	   IgG.	   A)	   Solutions	   of	  Cysteine•HCl	  were	  used	  to	  generate	  a	  standard	  curve	  to	  B)	  quantify	  the	  number	  of	  thiol	  groups	  added	  per	  human	  IgG	  molecule.	  Reactions	  with	  Ellman’s	  reagent	  were	  measured	   in	   triplicate	   for	   absorbance	   at	   412	   nm	   using	   a	   NanoDrop	  spectrophotometer.	  Averaged	  data	  are	  presented.	  	  There	   is	   precedent	   for	   the	   use	   of	   Ellman’s	   reagent	   for	   sulfhydryl	  quantification	  during	  NP	  functionalization.	  Bedeneau	  and	  colleagues	  (2007)	  used	  a	  milliliter-­‐scale	  Ellman’s	  reagent-­‐based	  assay	  to	  determine	  thiolation	  of	  monoclonal	  antibodies	  for	  attachment	  to	  nanoscale	  liposomes	  via	  a	  similar	  Mal-­‐PEG	  linker.33	  The	  present	   study	   transformed	   this	   assay	   to	   conserve	   thiolated	   protein	   sample,	  optimizing	  to	  a	  28	  μl	  reaction	  per	  sample	  (Section	  2.1.2.2).	  	  Three	  spectrophotometers	  were	  compared	  to	  optimize	  the	  reproducibility	  of	  the	  micro-­‐scale	  Ellman’s	  assay	  and	  optimize	  sample	  conservation	  and	  accuracy.	  The	  NanoDrop	   and	   Molecular	   Devices	   SpectraMax	   190	   spectrophotometers	   (Fig.	   17A	  and	   17B	   respectively)	   require	   a	   4	   μl	   reaction	   volume	  whereas	   Cary	   50	   (Fig	   17C)	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requires	  at	   least	  750	  μl.	  Three	  acquisitions	  were	  necessary	   to	  generate	   consistent	  results	  on	   the	  NanoDrop	   instrument	  and	  data	  reflect	   the	  average	  absorbance	  (Fig.	  17A).	  	  
	  
Figure	  17.	  Absorbance	  at	  412	  nm	  of	  standard	  Cys•HCl	  solutions	  reacted	  with	  
Ellman’s	  reagent	  measured	  via	  A)	  NanoDrop,	  B)	  SpectraMax	  190	  Plate	  Reader,	  
and	   C)	   Cary	   50.	   Linear	   regression	   applied	   and	   lines	   of	   best	   fit	   and	   correlation	  coefficient	  shown.	  All	  three	  instruments	  generated	  acceptable	  standard	  curves	  with	  solutions	  of	  cysteine•HCl,	   leading	   to	   the	   exclusion	   of	   the	   high	   volume	   Cary	   50	   for	   sample	  conservation	   in	   this	   assay.	   Increased	   standard	   solutions	   with	   thiol	   concentration	  between	   0	   and	   0.5	   mM	   were	   used	   to	   compare	   NanoDrop	   and	   SpectraMax	   190	  spectrophotometers	  in	  reading	  the	  Ellman’s	  based	  assay,	  as	  most	  thiolated	  protein	  samples	   have	   low	   sulfhydryl	   concentrations	   and	   thus	   efficacy	   in	   this	   range	   was	  
































































critical	   for	   assay	   optimization.	   Standard	   deviation	   was	   not	   comparable	   between	  instruments,	  as	  absorbance	  data	  were	  acquired	  on	  a	  different	  (unknown)	  scale	  for	  each.	  The	  SpectraMax	  190	  instrument	  (Fig	  17B)	  optimized	  sample	  volume	  and	  was	  able	   to	   read	   absorbance	   with	   greater	   precision.	   As	   an	   automated	   plate-­‐reader	  system,	  it	  also	  was	  more	  controlled	  and	  easy	  to	  use	  and	  was	  thus	  determined	  to	  be	  the	  best	   instrument	   to	  read	   the	  28	  μl	   sulfhydryl	  quantification	  assay	  developed	   in	  this	   study.	   	   With	   data	   collection	   methods	   optimized,	   a	   reliable	   small-­‐volume	  Ellman’s	  reagent	  based	  thiol	  quantification	  was	  successfully	  developed	  for	  use	  as	  a	  characterization	  step	  in	  NP	  functionalization.	  After	   thiolation,	   targeting	   antibodies	   were	   next	   conjugated	   to	   Mal-­‐PEG	  linkers	  for	  subsequent	  attachment	  to	  silica-­‐coated	  SPIO	  NPs.	  As	  a	  proof	  of	  concept,	  thiolated	   IgG	   was	   purified	   by	   desalting	   column	   (7	   kDa	   cut	   off)	   and	   coupled	   to	  Maleimide,	  Biotin,	  heterobifunctional	  PEG	  (MW	  525.6	  g/mol).	  After	  another	  round	  of	   protein	   purification,	   antibody-­‐PEG	   conjugation	   was	   confirmed	   via	  chemiluminescent	  dot	  blot	  for	  biotin	  (Fig.	  18).	  
	  	  
Figure	   18.	   Conjugation	   of	   IgG	   to	   Mal-­‐PEG-­‐Biotin	   confirmed	   via	  




This	  pilot	   study	  provides	  evidence	   for	   the	  efficacy	  of	   the	  antibody-­‐Mal-­‐PEG	  conjugation	  system,	  despite	  its	  lack	  of	  directional	  specificity.	  Attachment	  of	  protein	  A/G	  via	  the	  thiol	  linkage	  and	  subsequent	  conjugation	  of	  a	  targeting	  antibody	  via	  the	  strong	   interaction	  between	  Protein	  A/G	  and	   the	  FC	  portion	  of	   immunoglobulins	   is	  one	  solution	  to	  achieve	  the	  desired	  orientation	  of	  this	  functional	  moiety.11	  
3.2.3	  Functionalization	  with	  Monoclonal	  Antibody	  CHO	  31.1	  	  The	   optimized	   thiol-­‐Mal-­‐PEG-­‐silane	   linkage	   scheme	   was	   applied	   towards	  conjugating	  the	  targeting	  antibody	  CHO	  31.1	  to	  the	  NP	  surface	  (Fig.	  19).	  	  
	  
Figure	  19.	  Conjugation	  scheme	  for	  attachment	  of	  monoclonal	  antibody	  31.1	  to	  






























column	  and	  conjugated	  to	  5	  kDa	  Mal-­‐PEG-­‐Silane.	  After	  another	  round	  of	  purification,	  PEGylation	   of	   antibody	   was	   analyzed	   via	   the	   barium	   chloride	   assay	   for	   PEG	  described	  in	  section	  2.2.4	  (Fig.	  20).26	  Even	  50	  and	  100-­‐fold	  diluted	  samples	  showed	  coloring	  beyond	  the	  range	  of	  the	  assay.	  
	  	  
Figure	   20.	   Confirmed	   conjugation	   of	   31.1	   to	   Mal-­‐PEG-­‐Silane	   via	   PEG,	   BaCl	  
assay.26	  Columns	  1-­‐5)	  Standard	  curve	  of	  5	  solutions	  containing	  0,	  1,	  2.5,	  3.75,	  5,	  6.25,	  7.5,	  and	  10	  μg/ml	  mPEG	  were	  performed	  in	  replicate.	  Columns	  6	  and	  7	  correspond	  to	  1/50	  and	  1/100	  dilutions	  of	  PEGylated	  CHO	  31.1	  were	  analyzed	   in	  duplicate	  as	  well.	  	   Following	   collection	   of	   NPs	   by	   magnet	   and	   two	   washes	   with	   PBS,	   a	  chemiluminescent	  dot	   blot	   for	   human	  protein	  was	  used	   to	   confirm	   conjugation	  of	  CHO	  31.1	  to	  the	  NP	  surface	  (Fig.	  21).	  
	   	  




Figure	   21.	   Conjugation	   of	   31.1	   to	   silica-­‐coated	   SPIO	   NP	   confirmed	   via	  
chemiluminescent	  dot	  blot	  for	  human	  protein.	  Anti	  human	  antibody	  conjugated	  to	  HRP	  was	  used	  to	  detect	  CHO	  31.1	  in	  protein	  samples;	  positive	  controls	  A)	  IgG	  and	  B)	  CHO	  31.1,	   supernatants	   from	  PBS	  washes	  C)	  1	   and	  D)	  2	   respectively,	   and	  31.1	  conjugated	  SPIO	  NP	  sample.	  The	   conjugation	   of	   CHO	   31.1	   to	   silica-­‐coated	   SPIO	  NPs	  was	   achieved	   via	   a	  thiol	   linkage	   (Fig.	   21).	   Although	   this	   method	   does	   not	   allow	   control	   over	   the	  orientation	   of	   the	   coupled	   antibody,	   previous	   studies	   show	   that	   it	   does	  stochastically	   guarantee	   some	   functional	   moieties.14,	   34	   Thus	   the	   successful	  functionalization	  via	   the	   thiol	   linkage	  observed	  brings	  us	  a	   step	   closer	   to	  building	  directed	  silica-­‐coated	  SPIO	  NPs	  for	  the	  targeted	  delivery	  of	  chemotherapy.	  	  
3.3	  In	  Vitro	  Targeting	  Analysis	  Cellular	  assays	  were	  developed	  to	  evaluate	  MRI	  detection	  of	  NPs	  as	  well	  as	  their	   targeting	   and	   cellular	   internalization.	   Modified	   antibody	   molecules	   and	  commercially	   available	   NPs	  were	   used	   to	   develop	   these	   assays,	   for	   future	   use	   on	  novel	  NPs.	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3.3.1	  NP	  detection	  via	  MRI	  Using	  GoldMag@As33	  NPs	  GoldMag	  NPs	  functionalized	  with	  monoclonal	  antibody	  As33	  as	  described	  in	  the	  literature	  (by	  the	  Webb	  lab)	  were	  added	  to	  to	  both	  CAPAN-­‐2	  and	  BxPC3	  cells.35	  As33	   also	   targets	   glycoprotein	   A33	   expressed	   on	   CAPAN-­‐2	   and	   not	   expressed	   on	  BxPC3	   cells.	   Cultures	   were	   incubated	   for	   2	   hours,	   pelleted	   and	  washed	  with	   PBS	  either	  at	  pH	  7	  or	  pH	  3,	   then	   suspended	   in	  agarose	  and	   transferred	   to	  3	  mm	  NMR	  tubes	  for	  MR	  imaging.	  Washed	  cell	  pellets	  from	  samples	  treated	  with	  NPs	  were	  rust	  colored	  to	  the	  naked	  eye,	   indicating	  the	  presence	  of	  NPs	  (Fig.	  22B).	  Untreated	  and	  cell-­‐free	   samples	   showed	   expected	   T2	   times,	   confirmed	   by	   previous	   studies.14	  Darkening	  of	   the	  MR	   image	   in	  agarose	   suspensions	  of	   cells	   treated	  with	  SPIO	  NPs	  confirms	   that	   detection	   of	   NPs	   in	   cells	   via	  MRI	   is	   feasible	   qualitatively	   (Fig	   22A).	  Reduced	  T2	  time	  in	  the	  cells	  treated	  with	  NPs	  provides	  quantitative	  evidence	  of	  MRI	  detection	   of	   SPIO	   NPs	   in	   cellular	   samples,	   corroborating	   acellular	   MRI	   studies	   of	  SPIO	  NPs	  in	  the	  literature	  (Fig.	  22C).8,	  31,	  36	  	  




Figure	   22.	   MRI	   detection	   of	   GoldMag	   NPs	   conjugated	   with	   As33	   in	   treated	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Figure	  23.	  T2	  signal	  decay	  over	  time	  for	  agarose	  suspensions	  of	  A)	  BxPC3	  (B3)	  
and	  B)	  CAPAN-­‐2	  (C2)	  cells	  treated	  with	  with	  GoldMag@As33	  NPs	  and	  washed	  














Figure	   24.	   DAPI	   fluorescence	   localized	   to	   nuclei	   in	   CAPAN-­‐2	   and	   BxPC3	   cell	  
lines.	  Untreated	  cells	  adherent	  to	  glass	  cover	  slips	  were	  fixed	  and	  stained	  with	  the	  nuclear	  label	  DAPI	  using	  ProLong	  Gold	  mounting	  media	  with	  DAPI.	  Images	  taken	  at	  200x	  magnification	  using	  a	  Nikon	  80i	  fluorescence	  microscope.	  	  In	   parallel,	   absorbance	   and	   fluorescence	   of	   pHrodo-­‐Green	   fluorophore	  coupled	   to	   NH2-­‐PEG-­‐silane	   were	   evaluated	   via	   Molecular	   Devices	   SpectraMax	  M3	  microplate	   UV-­‐Visible	   spectrophotometer.	   Fluorescence	   spectra	   were	   collected	  using	  a	  490	  nm	  excitation	   (the	   closest	   filter	   to	  505	  nm	   in	   the	  plate	   reader	  UV-­‐Vis	  spectrometer	  (Fig.	  25)	  	  	  
	   	  
CAPAN-2 BxPC3?




Figure	   25.	   A)	   Absorbance	   and	  B)	   Fluorescence	   spectra	   of	   pHrodo-­‐Green	   (20	  
uM)	   in	  a	  pH	  4	  solution.	  Spectra	  were	  collected	  via	  Molecular	  Devices	  SpectraMax	  M3	  microplate	  UV-­‐Visible	  spectrophotometer.	  λex	  for	  B	  was	  490	  nm.	  	   Fluorescence	  measurements	  were	  confounded	  by	  excitation	  light,	  yielding	  a	  saturated	   emission	   spectrum,	   but	   an	   experimental	   absorbance	   maximum	   was	  observed	  between	  500	  nm	  and	  510	  nm	  in	  an	  20	  μM	  solution	  with	  a	  pH	  of	  4	  (Fig.	  25),	  consistent	  with	  the	  manufacturer’s	  specification	  of	  505	  nm	  (Fig.	  26).	  
	  
Figure	  26.	  Manufacterer’s	  absorption	  and	  Emission	  spectra	  of	  pHrodo-­‐Green	  
fluorophore,	  along	  the	  visible	  electromagnetic	  spectrum.5	  





























Emission	   spectra	   of	   20	   μM	   pHrodo-­‐Green	   in	   solutions	   of	   variable	   pH	   are	  shown	   below,	   and	   result	   from	   an	   excitation	   wavelength	   of	   490	   nm	   (Fig.	   27).	  Solutions	  were	  prepared	  in	  duplicate	  and	  the	  scatterplot	  below	  represents	  average	  fluorescence	   intensity.	   Saturation	   around	   500	   nm	   in	   addition	   to	   10	   nm	   step	  collection	  resulted	   in	  a	   fragmented	  spectrum	  between	  470	  nm	  and	  510	  nm.	  These	  spectra	  do	  not	  have	  sufficient	  resolution	  to	  demonstrate	  the	  desired	  pH	  dependence	  of	  pHrodo-­‐Green.	  
	  
Figure	   27.	   Average	   fluorescence	   intensity	   of	   pHrodo	   Green	   (20	   uM)	   in	  






























Fluorophore	   pHrodo-­‐Green	   is	   known	   to	   show	   a	   non-­‐linear	   change	   in	  fluorescence	   in	   response	   to	   pH	   changes,	   and	   thus	   has	   been	   faulted	   as	   a	   poor	  environmental	  pH	  sensor.37	  However,	  pHrodo-­‐Green	  presents	  an	   ideal	   tool	   for	   the	  purpose	   of	   determining	   internalization,	   as	   it	   shows	   dramatically	   different	  fluorescence	  between	  the	  pH	  7	  and	  pH	  3,	  the	  approximate	  pH	  in	  cell	  media	  versus	  in	  the	   late	   endosome	   (Fig.	   28).	   	   Examining	   emission	   of	   well-­‐mixed	   solutions	   in	   the	  relevant	  region	  of	   the	  electromagnetic	  spectrum	  yielded	  a	  clear	  trend	  of	   increased	  fluorescence	  with	  decreasing	  pH.	  Quenching	  effects	  of	  NPs	  were	  also	  considered	  at	  about	   a	   1:1	  molar	   ratio	  with	   pHrodo.	  No	  difference	   in	   fluorescence	  was	   observed	  between	  samples	  with	  (Fig.	  28A)	  and	  without	  (Fig.	  28B)	  NPs,	  indicating	  that	  the	  NPs	  used	  do	  not	  quench	  fluorescence.	  
	  
Figure	  28.	  Increasing	  fluorescence	  of	  pHrodo-­‐Green	  with	  decreasing	  pH	  in	  the	  














































To	  more	  easily	  identify	  the	  trend	  of	  fluorescence	  with	  varying	  pH,	  as	  well	  as	  compare	   fluorescence	   of	   pHrodo-­‐Green	   in	   the	   presence	   and	   absence	   of	   SPIO	  NPs,	  single	   wavelength	   experiments	   (end	   point	   setting)	   were	   conducted,	   measuring	  emission	  at	  538	  nm	  (Fig.	  29).	  This	  acquisition	  mode	  also	  minimized	  collection	  time.	  	  
	  
	  
Figure	   29.	   Endpoint	   fluorescence	   of	   pHrodo-­‐Green	   in	   the	   presence	   of	   SiO2	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Following	   the	   optimization	   of	   the	   fixation	   and	   nuclear	   labeling	   protocol,	  CAPAN-­‐2	  and	  BxPC3	  cells	  were	  again	  cultured	  on	  glass	  coverslips	  and	  treated	  with	  As33@pHrodo-­‐Green	   for	   1.5	   hours.	   Cells	   retained	   normal	   morphology	   when	  cultured	   on	   coverslips	   and	   after	   treatment.	   The	   treated	   cells	  were	   then	   fixed	   and	  imaged	  using	  a	  Leica	  TCS	  SP5	  confocal	  microscope.	  Excitation	  and	  detection	  settings	  were	   optimized	   for	   the	   pHrodo-­‐Green	   fluorophore,	  which	   emits	   light	   intensely	   at	  505	  nm	  under	  488	  nm	  excitation	  in	  low	  pH	  environments	  (pH	  3-­‐5).	  CAPAN-­‐2	  cells	  showed	  clear	   co-­‐labeling	  of	  pHrodo	  and	  DAPI,	   confirming	  cellular	   localization	  and	  internalization	  of	  As33	  antibody	  (Fig.	  30).	  	  
	  	  
Figure	   30.	   Co-­‐labeling	   of	   pHrodo-­‐Green	   and	   DAPI	   nuclear	   stain	   in	   CAPAN-­‐2	  




bottom	  of	   the	  cell	  where	   it	   is	  adhered	  to	   the	  coverslip	  (31CD).	  This	  observation	   is	  explained	   by	   the	  mode	   of	   exposure,	   as	   As33@pHrodo-­‐Green	  was	   administered	   in	  cell	  media	  and	  thus	  would	  have	  been	  internalized	  from	  the	  top	  of	  the	  cell.	  After	  1.5	  hours,	   vesicles	   containing	   endocytosed	   antibodies	   may	   not	   have	   traveled	   to	   the	  bottom	  of	  the	  cell,	  resulting	  in	  a	  loss	  of	  signal	  in	  images	  taken	  closer	  to	  the	  coverslip.	  	  
	  	  






As33@pHrodo.	  This	  observation	  supports	  As33	  targeting	  toward	  glycoprotein	  A33,	  overexpressed	   in	   the	   CAPAN-­‐2	   cell	   line	   and	   not	   present	   on	   the	   surface	   of	   BxPC3	  cells.14	  
	  	  
Figure	   32.	   pHrodo-­‐Green	   and	  DAPI	   co-­‐labeling	   of	   BxPC3	  primary	   pancreatic	  





SPIO	  NPs	  as	  exogenous	  contrast	  agents	  in	  addition	  to	  vehicles	  for	  targeting	  therapy.	  However,	  caution	  must	  be	  exercised	  in	  translating	  this	  multifunctional	  therapy	  from	  the	   lab	  to	  the	  clinic,	  as	  toxicity	  of	  SPIO	  NPs	  has	  recently	  gained	  ground	  as	  a	  major	  obstacle	   to	   use	   in	   humans.7,	  11,	  21	  Multifunctional	   SPIO	  NPs	   hold	   great	   promise	   for	  diagnostic	   and	   therapeutic	   use	   in	   medicine,	   but	   further	   investigation	   of	   their	  interactions	  with	   the	   body,	   on	   a	   cellular	   and	   systems	   level,	  must	   be	   conducted	   in	  order	   successfully	   translate	   this	   versatile	   vehicle	   into	   a	   diagnostic	   and/or	  therapeutic	  tool	  in	  the	  clinic.	  
	   	  
Nagalla	  2014	  
60	  
4	  Conclusions	  and	  Suggestions	  for	  Future	  Work	  In	  this	  work,	  I	  have	  successfully:	  	  
♦ Constructed	  NPs	  functionalized	  with:	  -­‐ CHO	  31.1	  	  -­‐ PEG	  
♦ Produced	   preliminary	   evidence	   for	   the	   targeting	   of	   As33	   towards	   cells	  expressing	  target	  antigen	  A33.	  
♦ Produced	  evidence	   for	   the	   internalization	  of	  As33	   into	  pancreatic	  cancer	  cells	  via	  an	  endocytotic	  mechanism.	  
♦ Developed	  a	  micro-­‐scale	  assay	  for	  sulfhydryl	  quantification.	  
♦ Optimized	  a	  cellular	  assay	  to	  measure	  MRI	  detection	  of	  SPIO	  NPs	  in	  vitro.	  
♦ Developed	   an	   in	   vitro	   targeting	   assay	   using	   confocal	  microscopy	   to	   visualize	  internalization	  of	  the	  targeting	  moiety.	  	  	  Future	  directions	  for	  this	  project	  include:	  	  
♦ Confirming	   the	  viability	  of	  NP-­‐based	   immuno	   targeting,	   repeat	   internalization	  study	  with	  NPs	  conjugated	  with	  As33	  or	  31.1.	  
♦ Building	  multifunctional	  SiO2	  coated	  NPs	  	  -­‐	  conjugated	  with	  both	  antibody	  and	  pHrodo	  or	  antibody	  and	  treatment.	  
♦ Conducting	   internalization	   and	   MRI	   detection	   experiments	   with	   fully	  functionalized	  NPs.	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Appendix	  I:	  Protocols	  IA:	  TEM	  Imaging	  	  Goldenson	  Building,	  Harvard	  Medical	  School,	  Boston,	  MA	  1. Place	  grid	  into	  chamber	  in	  probe;	  align	  and	  insert	  probe	  into	  TEM	  instrument	  evacuation	  chamber.	  2. When	   1	   cycle	   of	   evacuation	   has	   completed,	   push	   home	   into	   main	   column	   of	  instrument	  (the	  imaging	  chamber	  is	  kept	  evacuated	  at	  all	  times).	  3. Tune	  electron	  beam	  to	  the	  center	  of	  the	  gross	  view	  stage	  using	  control	  knobs.	  4. Select	  magnification	  of	  the	  digital	  controls	  to	  the	  right	  of	  the	  instrument	  (start	  at	  40-­‐50kV).	  5. View	  image.	  Update	  scale	  bar	  before	  saving	  images	  for	  accuracy.	  6. Use	  “Measure	  On”	  to	  take	  direct	  measurements.	  7. To	  save	  image:	  select	  “Click	  for	  Final	  Image.”	  8. To	  close	  down:	  turn	  of	   filament	  by	  bringing	  control	  knob	  to	  zero.	  Turn	  off	  HT	  (high	  tension)	  and	  then	  remove	  probe	  from	  instrument	  to	  retrieve	  grid.	  Always	  replace	  the	  probe	  in	  evacuation	  chamber	  of	  the	  instrument.	  
	  










• Use	  the	  wobble	  function	  for	  automatic	  focusing.	  	  
• FFT	  corrects	  for	  astigmatism	  
• Round	  and	  diffuse	   light	   is	  best	   for	  high	  magnification	  –	  alter	  with	  Δdef	  (xy)	  and	  objective	  focus	  controls.	  
• Use	  100kV	  for	  high	  magnification	  imaging	  
IB:	  Monolayer	  Cell	  Culture	  Protocol	  in	  Flasks	  and	  on	  Microscope	  Cover	  Slips	  General	  Passaging	  Preparation	  	  Half	  an	  hour	  prior:	  Warm	  RPMI	  complete	  media,	  sterile	  PBS,	  and	  sufficient	  trypsin	  in	  the	  hood	  or	  place	  in	  warm	  water	  bath.	  	  1. Wash	  cells	  with	  5	  mL	  PBS	  to	  remove	  debris	  and	  dead	  cells.	  2. Add	  3	  mL	  trypsin	  to	  detach	  cells.	  3. Incubate	  3	  min	  in	  incubator.	  Tap	  to	  detach	  cells	  from	  plastic.	  4. Add	  8	  ml	  RPMI	  media	  and	  blow	  over	  bottom	  of	  flask	  to	  detach	  cells.	  5. Transfer	  to	  15	  ml	  centrifuge	  tube	  and	  centrifuge	  to	  pellet	  cells	  3	  min	  1000	  RPM	  on	  DuPont	  Sorvall	  TC	  6	  machine.	  6. Draw	  off	  supernatant	  and	  resuspend	  cells	  in	  RPMI	  media	  for	  seeding.	  
	   T-­‐25	  flask	  monolayer	  culture:	  	   	   Prepare	  cells	  as	  for	  passaging.	  Seed	  2x106	  -­‐7x106	  cells	  per	  flask	  and	  add	  3-­‐5	  ml	  RPMI	  media.	  Cells	  reach	  confluence	  in	  2-­‐3	  days	  (BxPC3	  cell	  line	  grows	  faster	  than	  CAPAN-­‐2).	  Replace	  media	  after	  3	  days	  if	  cells	  not	  confluent.	  
	   Cover	  slip	  cell	  culture	  Protocol:	  	   	   Prepare	  cells	  as	  for	  passaging.	  For	  overnight	  preparation:	  	   Seed	  ~	  100,000	  cells	  per	  coverslip	  from	  monolayer	  culture	  ~60%	  confluent	  (1:15	  dilution	  for	  t-­‐25).	  1. Suspend	  cells	  at	  106	  cells/mL	  and	  seeded	  100	  ul	  via	  1	  mL	  serological	  pipette.	  	  2. Allow	  to	  adhere	  to	  the	  glass	  for	  10	  min	  at	  37	  degrees	  (incubator)	  3. Add	  3	  ml	  media	  slowly	  	  4. Incubate	  o/n	  (12-­‐14	  hours)	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For	  1.5	  day	  preparation:	  	   Seed~50,000	  cells	  per	  coverslip	  (6x	  per	  well)	  from	  monolayer	  culture	  ~60%	  confluent	  (1:30	  dilution	  for	  t-­‐25).	  1. Suspend	  cells	  at	  5	  x	  105	  cells/mL	  and	  seeded	  100	  ul	  via	  1	  mL	  serological	  pipette.	  	  2. Allow	  to	  adhere	  to	  the	  glass	  for	  10	  min	  at	  37	  degrees	  (incubator).	  3. Add	  3	  ml	  media	  slowly.	  	  4. Incubate	  15-­‐19	  H.	  
IC:	  Cellular	  Fluorescent	  Labeling	  Protocol	  	  	   (Courtesy	  Professor	  Louise	  Darling	  -­‐	  Wellesley	  College)	  	  Cell	  Fixation:	  1. Check	  cells	  for	  confluence,	  normal	  morphology,	  and	  health	  under	  microscope	  2. Wash	  (#1.5)	  coverslips	  in	  the	  6-­‐well	  plate	  with	  2	  ml	  PBS	  to	  remove	  traces	  of	  phenol	  red	  and	  excess	  treatment.	  
On	  lab	  bench:	  
3. Fix	   cells	   in	   1	   ml	   4%	   Paraformaldehyde	   (PFA)(Boston	   BioProducts)	   for	   15	  min.	  a. Place	  “used”	  PFA	  in	  the	  labeled	  PFA	  waste	  container	  in	  chemical	  fume	  hood	  (warning:	  PFA	  is	  an	  environmental	  hazard	  and	  must	  not	  go	  
down	  the	  sink).	  4. Wash	  cover	  slips	  3	  times	  with	  PBS.	  5. Apply	   10-­‐20	   uL	   (one	   small	   drop)	   of	   ProLong	   Gold	   with	   DAPI	   (Life	  Technologies)	   to	   slide	   and	   immediately	   mount	   coverslip.	   Allow	   mounting	  media	  to	  spread	  to	  all	  areas	  of	  the	  coverslip.	  6. Seal	  coverslips	  with	  clear	  nail	  polish.	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ID:	  Confocal	  Microscopy	  Protocol	  (on	  Leica	  SP5	  instrument)	  Adapted	  from	  lab	  manual	  written	  by	  Jeannie	  Benton,	  Beltz	  Lab,	  Wellesley	  College.	  
• Powering	  on	  (green	  switches	  on	  right	  hand	  side):	  1. Power	  source	  for	  metal	  halide	  light	  source	  2. PC	  computer	  (log	  in)	  3. Scanner	  (wait	  20	  seconds	  and	  don’t	  touch	  the	  microscope)	  4. Laser	  (turn	  key	  also)	  5. Open	   LAS-­‐AF	   software	   on	   the	   computer.	   Deselect	   resonance	   scanner	   and	  click	  ok.	  	  
• Preparation	  for	  imaging:	  1. Select	  No	  for	  initialization	  of	  automated	  stage.	  2. Navigate	  to:	  Configuration	  >	  Laser	  	  3. Turn	  on	  Argon	  and	  405	  diode	  lasers	  –	  set	  to	  20	  percent	  laser	  power.	  4. Navigate	  to:	  Acquire	  	  5. Adjust	  power	  of	  lasers	  to	  50	  percent.	  	  
• Mount	   slide	   on	   stage,	   coverslip	   down,	   moving	   the	   microscope	   arm	  appropriately.	  
• Use	  broad	  spectrum	  excitation	  (UV	  -­‐	  controls	  on	  microscope)	  to	  achieve	  Kohler	  illumination.	  
• Select	  Live	  at	  the	  bottom	  left	  and	  adjust	  smart	  gain	  and	  smart	  offset	  knobs	  on	  the	  control	  panel	  to	  the	  left	  of	  the	  CPU.	  	  
• Set	  pinhole	  (1-­‐8	  AU),	  resolution	  (512x512	  to	  1024x1024),	  frame	  averages	  (3),	  imaging	  channel(s),	  and	  volume/number	  of	  steps	  (if	  applicable).	  
• Select	  Start	  to	  collect	  image	  according	  to	  specified	  parameters.	  	  
• To	  power	  off,	  reverse	  the	  power	  on	  instructions,	  leaving	  the	  laser	  button	  on	  for	  20	  minutes	  after	  turning	  the	  system	  off	  to	  allow	  the	  lasers	  to	  cool.	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IE:	  Preparation	  of	  Cellular	  Agarose	  Suspensions	  for	  MRI	  1. Seed	  CAPAN-­‐2	  and	  BXPC3	  cells	  each	  into	  3	  t-­‐12.5	  flasks	  to	  reach	  confluence	  overnight	   at	   37	   °C	   (add	   about	   thirty	   to	   sixty	   thousand	   cells	   if	   culture	  doubles	  every	  two	  hours).	  2. Confirm	  confluence	  in	  the	  morning	  –	  around	  2.5	  million	  cells	  per	  flask	  3. Remove	  media	  and	  replace	  with	  RT	  treatment	  media	  for	  each	  cell	  line:	  one	  control	   with	   RPMI	   media	   only,	   two	   with	   NPs	   at	   __mg/ml	   suspended	   in	  media.	  	  4. Incubate	  for	  2	  hours	  at	  37	  °C.	  Remove	  media	  and	  wash	  attached	  cells	  with	  3	  ml	  RT	  PBS.	  	  5. Detach	  cells	  from	  flask	  with	  2	  ml	  RT	  trypsin.	  Incubate	  for	  5	  minutes	  and	  tap	  flask	  on	  bench	  top	  to	   loosen	  cells.	   [Note:	  pipette	  media	  over	   inside	   face	  of	  flask	  to	  remove	  as	  many	  adhered	  cells	  as	  possible].	  6. Pellet	   the	   cells	   for	   3	   minutes	   at	   1000	   rpm	   at	   RT	   (TC6	   centrifuge)	   and	  remove	  trypsin/media	  supernatant.	  7. Resuspend	  pellet	  in	  500	  μl	  RT	  PBS,	  pipetting	  up	  and	  down	  until	  no	  clumps	  visible	   (uniform	  cloudy	   suspension).	  Move	   these	   suspensions	   to	   the	  37	   °C	  walk	  in	  incubator.	  8. In	  37	   °C	  walk	   in	   incubator,	  prepare	  2	  %	  agarose	   solution	   in	  PBS	  on	  a	  hot	  plate	  while	  stirring	  with	  magnetic	  stir	  bar.	  9. Cool	  agarose	   to	  37	   °C	  and	  mix	  100	  μl	   cell	   suspension	  with	  900	  μl	  agarose	  solution.	  	  10. Transfer	  to	  3	  mm	  NMR	  tubes,	  filling	  to	  the	  same	  level	  for	  all	  samples.	  11. Allow	  agarose	  to	  set	  at	  RT	  for	  20	  min	  prior	  to	  imaging.	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Appendix	  II:	  Supplemental	  Results	  Functionalization	  With	  As33	  via	  Protein	  A/G	  NP	  synthesis:	  Silica-­‐coated	  SPIO	  NPs	  used	   in	   this	  study	  were	   functionalized	  with	  As33@pHrodo	  in	  an	  orientation-­‐dependent	  manner	  using	  protein	  A/G	  and	  an	  out-­‐to-­‐in	  conjugation	  scheme	  as	  follows.	  Protein	  A/G	  was	  thiolated	  as	  described	  in	  section	   2.1.2.1	   and	   conjugated	   to	   5	   kDa	   MW	   Mal-­‐PEG-­‐silane,	   which	   was	   then	  tethered	  to	  the	  silica	  surface	  of	  the	  NPs	  for	  30	  hours	  at	  4	  °C.	  NPs	  were	  washed	  three	  times	   in	   PBS	   to	   remove	   excess	   protein	   A/G.	   NanoDrop	   instrument	   detected	   no	  absorbance	  at	  280	  nm	  in	  the	  supernatant	  of	  the	  third	  wash.	  Finally,	  As33@pHrodo	  was	   attached	   non-­‐covalently	   via	   the	   affinity	   of	   protein	   A/G	   for	   the	   FC	   region	   of	  antibodies.	  The	  last	  conjugation	  step	  was	  performed	  for	  30	  min	  at	  4	  °C	  and	  followed	  by	  collection	  and	  washing	  of	  NPs	  with	  PBS.	  	  	  These	  functionalized	  NPs	  were	  then	  used	  to	  treat	  both	  CAPAN-­‐2	  and	  BxPC3	  cells	   cultured	   on	   coverslips.	   Each	   coverslip,	   cultured	   overnight	   with	   50,000	   cells,	  was	  incubated	  with	  10	  μl	  NPs	  in	  1	  ml	  PBS	  for	  2	  hours.	  Cells	  were	  then	  washed	  and	  fixed,	  as	  described	  in	  section	  2.3.1	  and	  appendix	  IC,	  with	  mounting	  media	  containing	  DAPI	   nuclear	   stain.	   Confocal	   microscopy	   was	   used	   to	   image	   treated	   cells	   for	   co-­‐localization	  of	  DAPI	  and	  pHrodo	  signal	  (Fig.	  II.I).	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  Figure	  II.I.	  Confocal	  microscopy	  shows	  internalization	  of	  pHrodo-­‐conjugated	  silica-­‐coated	  NPs	  in	  CAPAN-­‐2	  and	  BxPC3	  cells.	  	  pHrodo	   appears	   to	   localize	   to	   the	   cell,	   and	   co-­‐localize	   with	   the	   nucleus,	  indicating	   internalization.	   Punctate	   distribution	   of	   pHrodo	   fluorescence	   supports	  internalization	   into	   endocytotic	   vesicles	   that	   are	   low	   in	  pH.	  As	   gauged	  by	  pHrodo	  fluorescence,	   NPs	   appear	   targeted	   towards	   CAPAN-­‐2	   cells,	   which	   express	  glycoprotein	  A33,	   the	   target	  of	   antigen	  of	  As33	  antibody.	  This	   finding	   shows	  both	  internalization	   and	   targeting	   of	   NPs	   conjugated	   to	   targeting	   antibodies.	   However,	  the	  NPs	  were	  not	   fully	   characterized	   after	   conjugation	   to	  As33@pHrodo	   and	   thus	  further	  studies	  must	  be	  conducted	  to	  verify	  these	  results.	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